<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_yhXNfsW">Wearable Devices in Cardiovascular Medicine</title>
				<funder ref="#_SSagNRj">
					<orgName type="full">HHS/NIH/National Institute of Diabetes and Digestive and Kidney Diseases</orgName>
					<orgName type="abbreviated">NIDDK</orgName>
				</funder>
				<funder ref="#_HsMhzBk">
					<orgName type="full">American Heart Association</orgName>
					<orgName type="abbreviated">AHA</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/100000968</idno>
				</funder>
				<funder ref="#_weRXUHv">
					<orgName type="full">HHS/FDA</orgName>
				</funder>
				<funder ref="#_vvG84p5">
					<orgName type="full">HHS/NIH/NHLBI</orgName>
				</funder>
				<funder ref="#_HyHAz9Q">
					<orgName type="full">Department of Health and Human Services (HHS)/National Institute of Health (NIH)/National Heart, Lung, and Blood Institute</orgName>
					<orgName type="abbreviated">NHLBI</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">© 2023 American Heart Association, Inc.</p>
				</availability>
				<date type="published" when="2025-06-08">June 8, 2025</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>Md Mobashir</roleName><forename type="first">Andrew</forename><surname>Hughes</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation">Vanderbilt University Medical Center , 2525 W End Ave , Suite 300A , Nashville , TN 37203 .</note>
								<orgName type="institution">Vanderbilt University Medical Center</orgName>
								<address>
									<addrLine>2525 W End Ave Suite 300A</addrLine>
									<postCode>37203</postCode>
									<settlement>Nashville</settlement>
									<region>TN</region>
									<country></country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hasan</forename><surname>Shandhi</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation">Vanderbilt University Medical Center , 2525 W End Ave , Suite 300A , Nashville , TN 37203 .</note>
								<orgName type="institution">Vanderbilt University Medical Center</orgName>
								<address>
									<addrLine>2525 W End Ave Suite 300A</addrLine>
									<postCode>37203</postCode>
									<settlement>Nashville</settlement>
									<region>TN</region>
									<country></country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hiral</forename><surname>Master</surname></persName>
							<idno type="ORCID">0000-0003-0019-3087</idno>
							<affiliation key="aff0">
								<note type="raw_affiliation">Vanderbilt University Medical Center , 2525 W End Ave , Suite 300A , Nashville , TN 37203 .</note>
								<orgName type="institution">Vanderbilt University Medical Center</orgName>
								<address>
									<addrLine>2525 W End Ave Suite 300A</addrLine>
									<postCode>37203</postCode>
									<settlement>Nashville</settlement>
									<region>TN</region>
									<country></country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jessilyn</forename><surname>Dunn</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation">Vanderbilt University Medical Center , 2525 W End Ave , Suite 300A , Nashville , TN 37203 .</note>
								<orgName type="institution">Vanderbilt University Medical Center</orgName>
								<address>
									<addrLine>2525 W End Ave Suite 300A</addrLine>
									<postCode>37203</postCode>
									<settlement>Nashville</settlement>
									<region>TN</region>
									<country></country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Evan</forename><surname>Brittai</surname></persName>
							<email>evan.brittain@vumc.org</email>
							<idno type="ORCID">0000-0001-5843-3392</idno>
							<affiliation key="aff0">
								<note type="raw_affiliation">Vanderbilt University Medical Center , 2525 W End Ave , Suite 300A , Nashville , TN 37203 .</note>
								<orgName type="institution">Vanderbilt University Medical Center</orgName>
								<address>
									<addrLine>2525 W End Ave Suite 300A</addrLine>
									<postCode>37203</postCode>
									<settlement>Nashville</settlement>
									<region>TN</region>
									<country></country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_EUZDKTR">Wearable Devices in Cardiovascular Medicine</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2025-06-08">June 8, 2025</date>
						</imprint>
					</monogr>
					<idno type="MD5">C8FD758BBE088C1BFC47768CCB77900C</idno>
					<idno type="DOI">10.1161/circresaha.122.322389</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T05:39+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords xml:id="_euK4gen">cardiac rehabilitation ◼ cardiology ◼ digital technology ◼ healthy lifestyle ◼ wearable electronic devices</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_RKcMx7s"><p xml:id="_9T27tTv"><s xml:id="_RHhMWFt">Wearable devices, such as smartwatches and activity trackers, are commonly used by patients in their everyday lives to manage their health and well-being.</s><s xml:id="_BDNmg72">These devices collect and analyze long-term continuous data on measures of behavioral or physiologic function, which may provide clinicians with a more comprehensive view of a patients' health compared with the traditional sporadic measures captured by office visits and hospitalizations.</s><s xml:id="_YCPMNfX">Wearable devices have a wide range of potential clinical applications ranging from arrhythmia screening of high-risk individuals to remote management of chronic conditions such as heart failure or peripheral artery disease.</s><s xml:id="_zfdGc6y">As the use of wearable devices continues to grow, we must adopt a multifaceted approach with collaboration among all key stakeholders to effectively and safely integrate these technologies into routine clinical practice.</s><s xml:id="_FhtmYdh">In this Review, we summarize the features of wearable devices and associated machine learning techniques.</s><s xml:id="_f33s3wy">We describe key research studies that illustrate the role of wearable devices in the screening and management of cardiovascular conditions and identify directions for future research.</s><s xml:id="_Hspsf6B">Last, we highlight the challenges that are currently hindering the widespread use of wearable devices in cardiovascular medicine and provide short-and longterm solutions to promote increased use of wearable devices in clinical care.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="17" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="18" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
		<surface n="19" ulx="0.0" uly="0.0" lrx="585.0" lry="783.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_bgB2VfC">T</head><p xml:id="_mPU77Un"><s xml:id="_U7HVust">he evolution of digital health technologies has allowed individuals to assume an active role in the management of their cardiovascular health and facilitated increased patient-provider contact.</s><s xml:id="_K7cCk2T">Wearable devices are digital medicine tools that process data captured by mobile sensors to generate measures of behavioral or physiological function such as physical activity (PA), heart rate (HR), heart rhythm, and sleep. <ref type="bibr" target="#b0">1</ref> The wearable device market is now a multibillion dollar industry. <ref type="bibr" target="#b1">2</ref></s><s xml:id="_ckSWt2N">A large population survey indicates that many individuals use a wearable device to promote healthy behaviors or to manage a diagnosed condition. <ref type="bibr" target="#b2">3</ref></s><s xml:id="_gsFbp3b">While the clinical integration of wearable devices remains in the earliest stages, their use has the potential to broadly impact cardiovascular medicine through lifestyle modifications for primary prevention, arrhythmia screening of at-risk individuals, and remote management of patients with established heart failure (HF) or peripheral artery disease, among other chronic cardiovascular conditions.</s><s xml:id="_uGXa5St">There are several factors limiting the clinical use of wearables including concerns about data privacy, device accuracy, regulatory and reimbursement policies, and lack of dedicated clinical staff to monitor, interpret, and respond to the vast amounts of data generated by devices.</s><s xml:id="_TbNAj96">Our work aims to provide an overview of and expand upon the previously published reviews on wearable devices in cardiovascular medicine. <ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref></s><s xml:id="_Yg6qYMP">4]<ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b6">[6]</ref><ref type="bibr" target="#b7">[7]</ref> In this review, we describe the features of consumer-grade, medical-grade, and research-grade devices, the analytical machine learning (ML) techniques that augment the clinical utility of wearable devices, the role of wearables in the diagnosis and management of common cardiac conditions, and the challenges that are limiting more widespread clinical adoption of wearables.</s><s xml:id="_AUPMhZF">Last, we propose a short-and long-term road map to maximize the value of wearable devices in clinical care and management of cardiovascular disease (CVD).</s><s xml:id="_tNWbgBe">blood pressure (BP), oxygen saturation, sleep, maximum oxygen uptake, and temperature.</s><s xml:id="_nnR5afg">As illustrated in Figure <ref type="figure" target="#fig_0">1</ref>, wearable devices have many potential clinical applications to enhance the screening and management of cardiovascular conditions.</s></p><p xml:id="_sVfES3R"><s xml:id="_NzYXP8b">Wearables may be divided into consumer-, medical-, or research-grade devices.</s><s xml:id="_HwtaWuw">A consumer-grade wearable is available in the market, advertised toward the broader population, and intended to function for fitness, wellbeing, or entertainment purposes.</s><s xml:id="_ubumQzr">A research-grade wearable may or may not be available in the market, is targeted for research scientists, and is intended to collect data for research purposes.</s><s xml:id="_yQTEvDa">A medical-grade wearable is available in the market but often only accessible with a prescription from a clinician, is advertised toward patients and clinicians, and is intended for medical applications.</s><s xml:id="_KdvNWeD">Importantly, with our above definitions, the designation of a wearable may change depending on the context of use.</s><s xml:id="_27t3sPk">This is particularly true for wearables with intended use for health-related measurements, where the line between consumer, medical, and research uses can become blurred.</s><s xml:id="_qqpxbeR">An example of this is the Fitbit smartwatch, which has been used frequently in clinical trials, medical contexts, and consumer contexts, for each context falling under our designation of research-, medical-, and consumer-grade wearables, respectively.</s><s xml:id="_AVjnkcp">Another aspect of medical-grade devices is that they fall under the Food and Drug Administration (FDA) oversight.</s><s xml:id="_KbCT9h4">A single wearable may have multiple functions, some of which fall under regulatory oversight and others which do not, making it difficult to classify the entire device into just one category (for example, irregular heart rhythm detection versus oxygen saturation measurement, which are regulated differently but available together on multiple devices at the time of writing).</s><s xml:id="_a6utaJS">Thus, as the field evolves, it may become appropriate to rethink the nomenclature to classify wearables.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9wZsZDk">Sensor Technology</head><p xml:id="_3m9b5Nw"><s xml:id="_hucJgW5">This section highlights the common sensing modalities utilized in wearable devices, as well as some novel sensing modalities that have demonstrated potential in this space (Figure <ref type="figure" target="#fig_0">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_SzUuVsW">Accelerometry</head><p xml:id="_k2zYMcv"><s xml:id="_5naCvyt">Accelerometers are microelectromechanical system sensors that measure the acceleration of an object through capacitive, piezoresistive, and piezoelectric effects. <ref type="bibr" target="#b8">8</ref></s><s xml:id="_cMPsZhV">ccelerometers are widely used in wearable devices to measure the volume and intensity of PA and energy expenditure. <ref type="bibr" target="#b8">8</ref></s><s xml:id="_MnXPy3F">Accelerometers can be placed in various locations of the body (ie, torso, arm, and ankle), but most smartwatches and activity trackers use the wrist position due to user comfort.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_JWRYJRq">Photoplethysmogram</head><p xml:id="_JNWDfWs"><s xml:id="_9T6eSb5">The photoplethysmogram signal is an optical measurement of the changes in blood volume in the microvascular tissue bed, which can be measured by shining a light on the skin and collecting the reflected or transmitted wave of the light with a photodetector. <ref type="bibr" target="#b9">9</ref></s><s xml:id="_xaB7BE4">Photoplethysmogram is widely used in wearable devices to track HR, heart rhythm, and pulse oximetry. <ref type="bibr" target="#b10">10</ref></s><s xml:id="_unjRdQt">Photoplethysmogram may ultimately have other health care applications including monitoring BP and vascular aging. <ref type="bibr" target="#b11">11</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_2qg3RjN">Electrocardiogram</head><p xml:id="_DtNx9gS"><s xml:id="_v6mYCk4">The ECG signal captures the propagation of electrical action potentials in the heart.</s><s xml:id="_yHXy7Tq">The ECG measures the difference in electrical potential between various points on the body with skin-mounted electrodes and depicts the depolarization and repolarization of the heart. <ref type="bibr" target="#b12">12</ref></s><s xml:id="_hxtPPyX">The ECG can be used to monitor HR, detect arrhythmias, and identify myocardial ischemia or infarction, among other applications.</s><s xml:id="_ERg7vRg">Wearable devices commonly use a patch for arrhythmia detection in the outpatient setting. <ref type="bibr" target="#b13">13</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_WvRWTE4">Seismocardiogram</head><p xml:id="_a3S3Rpd"><s xml:id="_3b9sbzr">The seismocardiogram signal is the local vibration of the chest wall that occurs with every cardiac cycle including movement of the heart, opening and closing of the heart valves, and movement of blood in the aorta.</s><s xml:id="_rYpzMaA">Seismocardiogram can be recorded using an accelerometer or gyroscope placed on the mid-sternum. <ref type="bibr" target="#b14">14</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_hnaQkqA">Nonstandard Abbreviations and Acronyms</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_KvTAkpq">AF</head><p xml:id="_6TZqUAM"><s xml:id="_VyhEfbe">atrial fibrillation AI artificial intelligence BP blood pressure CAD coronary artery disease CGM continuous glucose monitoring CPT current procedural terminology CR cardiac rehabilitation CVD cardiovascular disease DL deep learning EHR electronic health record FDA Food and Drug Administration HF heart failure HR heart rate JITAI just-in-time adaptive intervention ML machine learning PA physical activity RCT randomized controlled trial ReDS remote dielectric sensing RPM remote physiologic monitoring TIR time in range REVIEW 654 March 3, 2023 Circulation Research.</s><s xml:id="_mEJEBHv">2023;132:652-670.</s><s xml:id="_NAEbFPN">DOI: 10.1161/CIRCRESAHA.122.322389</s><s xml:id="_UBTH4ne">Hughes et al Wearable Devices in Cardiovascular Medicine</s></p><p xml:id="_vrJ7qBJ"><s xml:id="_QqarMwZ">Multiple studies have demonstrated the potential for seismocardiogram to estimate cardiac time intervals, <ref type="bibr" target="#b14">14</ref> estimate changes in hemodynamics, <ref type="bibr" target="#b14">14</ref> and characterize whether patients with HF are compensated or decompensated. <ref type="bibr" target="#b15">15</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_5AAAq3v">Ballistocardiogram</head><p xml:id="_D4Myh7K"><s xml:id="_Wqt78mH">The ballistocardiogram signal is a measurement of the recoil forces of the body in response to the cardiac ejection of blood into the vasculature.</s><s xml:id="_jfPTybr">Ballistocardiogram is generally recorded in the longitudinal Downloaded from <ref type="url" target="http://ahajournals.org">http://ahajournals.org</ref> by on June 8, 2025 REVIEW Circulation Research.</s><s xml:id="_nj5vGv3">2023;132:652-670.</s><s xml:id="_hWeQvJt">DOI: 10.1161/CIRCRESAHA.122.322389</s><s xml:id="_hvWEVua">March 3, 2023 655 Wearable Devices in Cardiovascular Medicine</s></p><p xml:id="_RyJyBKv"><s xml:id="_7KuaP22">(head to foot) direction using a modified weighing scale, bed, or table-based systems. <ref type="bibr" target="#b14">14</ref></s><s xml:id="_8AP4jmk">Researchers have demonstrated the potential for ballistocardiogram to estimate HR <ref type="bibr" target="#b14">14</ref> and assess the clinical state of patients with HF. 9</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_r8kbrhT">Continuous Glucose Monitoring</head><p xml:id="_PjAW2T9"><s xml:id="_hT7uamq">Continuous glucose monitoring (CGM) is a method of measuring glucose levels in the body in real time through a small sensor under the skin, typically on the abdomen or arm. <ref type="bibr" target="#b16">16</ref></s><s xml:id="_fDMvhxW">The sensor measures the glucose levels in interstitial fluid, which is connected to a transmitter that sends the glucose readings to a monitoring device or mobile phone.</s><s xml:id="_34769mx">Users can track their glucose over time and receive alerts when their glucose levels are too high or too low, which can help to prevent dangerous complications such as hypoglycemia or hyperglycemia.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_brC7FXn">Artificial Intelligence</head><p xml:id="_WUNyEYW"><s xml:id="_efNk22e">The enormous volume of information from wearable devices requires intelligent algorithms and computational power to generate meaningful information.</s><s xml:id="_MQBvwWQ">ML is a method of data analysis that automates analytical model building, which evolved to recognize patterns in data without explicitly programming for particular tasks.</s></p><p xml:id="_MFyjGUa"><s xml:id="_3vq6CqM">The advantages of ML are adaptability, scalability, automation, and the ability to handle multidimensional and multivariate data.</s><s xml:id="_6Tfc2rR">ML can be divided into supervised, semi-supervised, unsupervised, and reinforcement learning (Table <ref type="table">1</ref>).</s><s xml:id="_QS3Khue">In supervised learning, the outcome variable is known and the algorithm attempts to learn the relationship between the outcome variable (ie, atrial fibrillation [AF]) and the estimating variables (ie, raw ECG data and summary ECG metrics) using parametric and nonparametric algorithms.</s><s xml:id="_aS6M8eR">Supervised learning can be further classified for the intended tasks: regression (where the target variable is continuous, ie, HR), classification (where the target variable is discrete, ie, arrhythmia existence or not; type of arrhythmia), and forecasting (predicting future outcomes based on the past and present data, ie, prognosis in HF).</s><s xml:id="_B3wHdES">Unsupervised learning is used to investigate groupings or patterns in the data where the label is not known, and semi-supervised learning is used when labels are known for only a portion of the data.</s><s xml:id="_We8gn3b">Reinforcement learning algorithms focus on trial and error, where the model learns from past experiences and begins to adapt its approach in response to the situation to achieve the best possible result, which can be used for remote home monitoring and just-in-time adaptive interventions (JITAI).</s><s xml:id="_EY56TGV">Deep learning (DL) models-a branch of supervised ML-have become increasingly popular in recent years and have achieved excellent performance in many biomedical applications, particularly in detecting and predicting CVDs such as arrhythmias, myocardial infarction, HF, and coronary artery disease (CAD). <ref type="bibr" target="#b26">26</ref></s><s xml:id="_NVwXvcn">As opposed to more traditional ML models (ie, random forest, support vector machine), DL models are more complex in nature.</s><s xml:id="_s7ZKAHK">Although DL models have demonstrated superior performance in CVD detection, these models cannot easily learn from small data sets.</s><s xml:id="_xEvTE2p">More importantly, they require intelligent design and often result in very opaque algorithms that are challenging to interpret and have a higher chance of overfitting.</s><s xml:id="_jtyzHjT">In addition, these algorithms learn and save millions of parameters, which requires extensive computational power to train the models.</s><s xml:id="_vCFk7gD">As such, DL models are difficult to deploy on wearable hardware, which are usually limited in computation power and storage space.</s></p><p xml:id="_RWDtEsZ"><s xml:id="_WyRChGk">Traditional ML and DL algorithms can reduce noise in the data, particularly wearable data (ie, motion artifact and intrasubject and intersubject variabilities), and extract relevant information from high-dimensional data.</s><s xml:id="_hFPxmf8">Representation learning is a method used in ML/DL to extract useful information from raw data. <ref type="bibr" target="#b27">27</ref></s><s xml:id="_98uhwAN">he goal of representation learning is to find a compact and informative representation of the data, in a way that captures the most important information and discards the noise or irrelevant information.</s><s xml:id="_JTVjbvs">This can be done by training a neural network to learn a set of features from the data or by using unsupervised learning techniques such as clustering or dimensionality reduction.</s><s xml:id="_wn8Q45a">Once the data have been transformed into a more useful representation, it can be used for various tasks such as classification, regression, or generation.</s><s xml:id="_UYNuGU5">Representation learning is particularly useful when the data are high dimensional, unstructured, or difficult to understand, as it can make it easier to extract insights or make predictions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_HRrK6Yp">WEARABLES IN CLINICAL CARE</head><p xml:id="_CRQ2rAj"><s xml:id="_DXAcrh4">This is not designed as a systematic review.</s><s xml:id="_5VtgCsR">Instead, the aim of this section is to highlight the pivotal clinical trials or novel proof-of-concept studies on the use of wearable devices in the screening and management of cardiovascular conditions (Table <ref type="table">2</ref>).</s><s xml:id="_M4sNkTF">Primary literature was acquired by searching for articles with key words such as wearables, smartwatch, mHealth, telemonitoring, etc.</s><s xml:id="_NpvafCw">The referenced articles are not exhaustive but were selected based on the level of evidence or number of citations with some additional studies included at the authors' discretion to illustrate findings that may help inform future directions.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_AsydyEM">Physical Activity</head><p xml:id="_NnaBBeN"><s xml:id="_PvcGR5g">Physical inactivity increases the likelihood of premature mortality or morbidity from CAD, type 2 diabetes, REVIEW 656 March 3, 2023 Circulation Research.</s><s xml:id="_5TDwKk7">2023;132:652-670.</s><s xml:id="_uax3UMQ">DOI: 10.1161/CIRCRESAHA.122.322389</s><s xml:id="_Zu8Au9R">Hughes et al Wearable Devices in Cardiovascular Medicine</s></p><p xml:id="_VedPqW9"><s xml:id="_H5Vqk7t">and mental illness. <ref type="bibr" target="#b54">54</ref></s><s xml:id="_rr45wRb">For example, a prospective cohort study of 16 741 older women demonstrated an inverse relationship between daily steps at enrollment, measured with an accelerometer for 7 consecutive days and allcause mortality as higher daily step totals were associated with lower mortality rates until the benefit plateaued around 7500 steps/day. <ref type="bibr" target="#b28">28</ref></s><s xml:id="_2hBCuxm">A longitudinal cohort study leveraged the "All of Us" research program to demonstrate an association between activity levels and incident chronic diseases with commercial wearable devices that were linked to an individual's electronic health record (EHR). <ref type="bibr" target="#b55">55</ref></s><s xml:id="_dFZgjKm">In a cohort of 6042 participants with a total of 5.9 million person-days of monitoring, higher daily step counts were associated with a reduced risk of several chronic diseases including hypertension, diabetes, obesity, and sleep apnea.</s><s xml:id="_rMtEKRD">Given that many adults fail to reach suggested levels of PA, this is a relevant public health issue that warrants attention.</s><s xml:id="_ZPfmhw9">There are hundreds of randomized controlled trials (RCTs) testing the use of activity trackers in various populations.</s><s xml:id="_C7Xfgrm">One umbrella review suggested that interventions that incorporate wearable devices increase PA by ≈1800 steps per day, walking by 40 minutes per day, and moderate-to-vigorous PA by 6 minutes per day. <ref type="bibr" target="#b1">2</ref> The umbrella review demonstrated an average weight loss of 1 kg with wearable PA interventions.</s><s xml:id="_8TRu55b">The impact on other clinical outcomes (ie, BP, lipid profile, and hemoglobin A1c) and quality-of-life outcomes was modest and often statistically insignificant.</s><s xml:id="_TJRP9eD">However, changes in these clinical outcomes may be delayed relative to PA and may need longer follow-up to become apparent.</s><s xml:id="_GGJpCXR">The umbrella review was comprehensive and included a wide range of interventions.</s><s xml:id="_3vmNFeN">For example, one intervention aimed to improve PA in a worksite environment by automatically transmitting data from activity trackers to an internet-based program to provide employees with daily step goals through emails or text messages, which had been adapted based on their activity levels. <ref type="bibr" target="#b56">56</ref></s><s xml:id="_PpEYdba">While this stand-alone intervention was completely automated, there were other studies with interventions that combined the wearable device with counseling sessions to create a multifaceted intervention.</s><s xml:id="_9mp4XPC">Brickwood et al <ref type="bibr" target="#b29">29</ref> demonstrated that multifaceted interventions (ie, wearable device and group or individual counseling) improved PA more effectively than interventions that only utilized wearable devices.</s><s xml:id="_ANj2wmR">One systematic review and meta-analysis focused specifically on interventions with wearable PA devices in patients with cardiometabolic conditions. <ref type="bibr" target="#b30">30</ref></s><s xml:id="_WGyYYtn">The review analyzed 38 RCTs with 4203 total patients and found the interventions that combined wearable PA devices and regular follow-up sessions with health care providers (face to face or remotely) were associated with increased activity levels.</s></p><p xml:id="_P9cfAnR"><s xml:id="_aU5N8xa">Behavioral change techniques such as personalized text messages, gamification, or JITAIs may enhance the impact of wearable devices on PA.</s><s xml:id="_XagCKKe">The mActive study demonstrated that the combination of</s></p><p xml:id="_7XE3qW4"><s xml:id="_ByrtcBR">Table 1.</s><s xml:id="_Zfp3m2G">Common Machine Learning Algorithms and Potential Clinical Applications in Cardiovascular Medicine Type Tasks Algorithms Clinical utility Potential clinical applications Supervised learning Regression Linear regression; polynomial regression; support vector regression; decision tree regression; random forest regression; lasso regression; ridge regression; boosting algorithms Estimating a numeric and continuous clinical outcome Estimating cardiorespiratory fitness (VO 2 ) 17 ; predicting measurements such as resting HR, skin temperature, fasting plasma glucose, hemoglobin A1C 18 Classification Support vector machine; logistic regression; random forest; boosting algorithms (ie, gradient boosting machine, AdaBoost); DL models (ie, deep neural network, convolutional neural network) Estimating a discrete/ binary clinical outcome Arrhythmia detection 19 ; assessment of LV function 20 ; compensated vs decompensated HF 9,15,17 Forecasting Prophet; recurrent neural network (ie, longshort-term memory network) Outcome prediction Prediction of CAD, HF, stroke, and arrhythmias 21 Semi-supervised learning Classification where labels are only available for a portion of the data.</s><s xml:id="_Q7NFy4g">Generative adversarial network; long-short-term memory network Training on a small pool of data, which is labeled for use on a larger pool of data to label/cluster the unlabeled data.</s><s xml:id="_NY4ccCt">CVD risk prediction from wearable data combined with EHR data 22 Unsupervised learning Clustering K-means clustering; spectral clustering; hierarchical clustering; gaussian mixture model Identifies groups/clusters in the data.</s><s xml:id="_G7qvBRB">It can be used as a preprocessing step for supervised learning.</s><s xml:id="_pnYgrht">Outlier removal from wearable data 23 Dimension reduction Principal component analysis; isomap embedding; spectral embedding; locally linear embedding; t-distributed stochastic neighbor embedding; multidimensional scaling Visualizing multimodal wearable features in a low dimensional space Visualizing wearable data against outcome variable such as SCG and BCG trends with changes in cardiac contractility due to exercise 24 Reinforcement learning Automate decisionmaking Deep Q networks Personalized interventions Remote monitoring and personalized management of comorbidities (ie, type 2 diabetes), which may include just-intime adaptive interventions 25 BCG indicates ballistocardiography; CAD, coronary artery disease; CVD, cardiovascular disease; DL, deep learning; EHR, electronic health record; HF, heart failure; HR, heart rate; LV, left ventricle; SCG, seismocardiography; and VO 2 , oxygen uptake.</s><s xml:id="_Mk3xx5g">Downloaded from <ref type="url" target="http://ahajournals.org">http://ahajournals.org</ref> by on June 8, 2025 REVIEW Circulation Research.</s><s xml:id="_P8xTb73">2023;132:652-670.</s><s xml:id="_XVxgxsD">DOI: 10.1161/CIRCRESAHA.122.322389</s><s xml:id="_JcsCjEq">March 3, 2023 657 Wearable Devices in Cardiovascular Medicine Table 2. Selected Clinical Studies of Cardiovascular Management With Wearable Devices Study Study design (n) Wearable device Measurement Major findings Physical activity Lee et al 28 Prospective cohort study (n=16 741) Actigraph GT3X+ accelerometer (Actigraph Corp) Daily step counts and step intensity As daily steps increased, the mortality rates decreased until it plateaued around 7500 steps/d in a large cohort of older women Brickwood et al 29 SR/MA of RCTs (n=3646) Variety of wearable activity trackers Daily step counts and step intensity Multifaceted interventions were more effective compared with interventions that relied solely on the wearable device Hodkinson et al 30 SR/MA of RCTs (n=4203) Variety of wearable activity trackers Daily step counts and step intensity Interventions that combine activity trackers and consultations with health care professionals can significantly improve the PA level in patients with cardiometabolic conditions ENGAGE study 31 RCT (n=500) Fitbit Alta or Fitbit Inspire (Fitbit, Inc) Daily step counts and step intensity There was a greater increase in PA when individuals selected their goals (rather than assigned) with immediate implementation in economically disadvantaged adults Ferguson et al 2 Umbrella review (n=163 992) Variety of wearable activity trackers Daily step counts and step intensity Wearables increase activity by an average of 1800 steps/d, 6 min of MVPA, and promote 1 kg of weight loss with sustainable effects for at least 6 mo AF REHEARSE-AF study 32 RCT (n=1001) AliveCor Kardia device Single-lead iECG Twice-weekly iPod ECG screening led to nearly 4-fold increase in new AF diagnosis in patients ≥65 y of age mSToPS study 13 RCT and observational cohort study (n=2659) Zio Patch (iRhythm Technologies) Single-lead ECG Monitored individuals had higher rates of AF diagnosis, AC use, and health care utilization Apple Heart Study 33 Prospective, multicenter, study (n=419 297) Apple Watch (Apple, Inc) PPG Irregular pulse notifications occurred in 0.52% of the population cohort, and the PPV of the notification was 0.84 for AF detection Huawei Heart Study 34 Prospective cohort study (n=187 912) Honor Band 4, Huawei Watch GT, Honor Watch (Huawei Technologies) PPG PPG identified suspected AF in 0.2% of the cohort, and the PPV of the notification was 91.6% EPACS study 35 RCT (n=116) Zio Patch (iRhythm Technologies) Single-lead ECG Continuous ECG monitoring after an index stroke/TIA resulted in significantly higher AF detection and AC use compared with Holter monitor SEARCH-AF study 36 RCT (n=336) SEEQ (Medtronic) or CardioSTAT (Icentia) chest patch Single-lead ECG Continuous ECG monitoring increased the rate of AF detection by 17.9% within 30 d of hospital discharge after cardiac surgery SCREEN-AF study 37 RCT (n=856) Zio Patch (iRhythm Technologies) and Watch BP-HomeA Monitor (Microlife) Single-lead ECG and oscillometric screening Continuous ECG monitoring increased AF detection 10-fold and led to AC initiation in 75% of patients ≥75 y old.</s><s xml:id="_8bj9bEu">BP monitor screening was inferior compared with continuous ECG HF TIM-HF study 38 RCT (n=710) Unspecified ECG and BP monitor 3-lead ECG and BP Telemonitoring with physician interventions did not reduce allcause mortality compared with usual care in ambulatory patients with stable HFrEF BEAT-HF study 39 RCT (n=1437) Unspecified BP+HR monitor Unspecified Telemonitoring with health coaching did not reduce readmission or mortality rates after an HF hospitalization TIM-HF 2 study 40 RCT (n=1571) PhysioMem PM 1000 (GETEMED) and UA 767 PBT BP device (A&amp;D Company) 3-lead ECG and BP Telemonitoring reduced the number of days lost to CV admissions and all-cause mortality in patients with HFrEF, no depression, and recent HF admission (subgroup of the TIM-HF study) LINK-HF study 41 Prospective multicenter study (n=100) Multisensor wearable chest patch (Vital Connect) PA, ECG, skin impedance, temperature ML algorithms detected rehospitalization with 76% to 88% sensitivity and 85% specificity, similar to the accuracy of implanted devices.</s><s xml:id="_9TgfTv7">Alerts preceded the readmission by 6.5 d Cardiac rehabilitation Telerehab II study 42 RCT (n=80) Yorbody Triaxial Accelerometer (Yorbody) Daily step counts and activity intensity The telemonitoring program combined with conventional CR increased the peak VO 2 more effectively than the control at 18 wk in patients with CAD Maddison et al 43 Noninferiority RCT (n=162) BioHarness 3 (Zephyr Technology) HR, RR, singlelead ECG, and PA Remotely monitored exercise-based cardiac telerehabilitation was similarly effective and had reduced program delivery costs compared with traditional center-based cardiac rehabilitation SmartCare-CAD study 44,45 RCT (n=300) Mio Alpha HR monitor (Physical Enterprises, Inc) and Actigraph wGT3x-BT triaxial accelerometer (Actigraph Corp) Physical activity intensity and HR Cardiac telerehabilitation with on-demand coaching was similarly effective to center-based CR for improvement in PA and QOL.</s><s xml:id="_Xya8QSC">The intervention was likely to be cost-effective (Continued ) REVIEW 658 March 3, 2023 Circulation Research.</s><s xml:id="_yAeT89x">2023;132:652-670.</s><s xml:id="_AQ3b3rA">DOI: 10.1161/CIRCRESAHA.122.322389</s><s xml:id="_K7Yj8BH">Hughes et al Wearable Devices in Cardiovascular Medicine</s></p><p xml:id="_37WyV5X"><s xml:id="_25u74Gq">automated, personalized text messages with activity trackers increased PA levels in outpatient cardiology patients.</s><s xml:id="_uCArX76">The text messages were either positive reinforcement if the individual was likely to reach the daily step goal (10 000 steps) or booster messages to provide motivation when they were unlikely to reach the daily goal. <ref type="bibr" target="#b57">57</ref></s><s xml:id="_hfuyTxA">A similar study design led to an increase of &gt;1000 steps per day and improved the quality of life in a population with pulmonary artery hypertension. <ref type="bibr" target="#b58">58</ref></s><s xml:id="_75VCUyW">Gamification integrates elements such as points or achievements to promote competition and facilitate positive lifestyle modifications. <ref type="bibr" target="#b59">59</ref></s><s xml:id="_79cTYqF">For example, the Behavioral Economics Framingham Incentive Trial (BE FIT) study of 200 adults comprising 94 families used a gamification intervention focused on behavioral economics principles to increase PA. <ref type="bibr" target="#b59">59</ref> Over the course of 12 weeks, the families were awarded 70 points at the start of each week.</s><s xml:id="_C8F7Fnb">One family member was randomly selected each day as their team's representative, and the family retained its points if that individual met their step goal on the previous day; otherwise, 10 points were deducted from the family's total.</s><s xml:id="_jspjKRG">This approach increased the average number of steps by ≈1700 steps/day, and a higher proportion of participants in the intervention arm achieved their daily step goals.</s><s xml:id="_uX9nvwH">Gamification interventions have successfully increased PA in a variety of populations including adults with uncontrolled diabetes, <ref type="bibr" target="#b60">60</ref> veterans with body mass index ≥25, <ref type="bibr" target="#b61">61</ref> and families in the general population. <ref type="bibr" target="#b59">59</ref></s><s xml:id="_kXmRa67">However, reports on the sustainability of PA improvements following gamification interventions have been mixed.</s><s xml:id="_ftQBSSZ">A systematic review on gamification interventions on PA demonstrated a very small to small effect on PA 12 to 24 weeks after the intervention, and the longterm effect was weaker and decreased over time. <ref type="bibr" target="#b62">62</ref></s><s xml:id="_BxShYJ7">he design of the gamification intervention seems to impact the sustainability of the results as one study in adults with obesity and type 2 diabetes demonstrated that a gamification with competition intervention sustained PA through 12 months more effectively compared with a gamification with support intervention in the same population. <ref type="bibr" target="#b60">60</ref></s><s xml:id="_MZpfFew">In contrast, a gamification intervention with social support and financial incentives in veterans with obesity demonstrated no sustainability over an 8-week period. <ref type="bibr" target="#b61">61</ref></s><s xml:id="_vkJNKMH">Given the mixed results on sustainability, it emphasizes the importance</s></p><p xml:id="_xrCXgyE"><s xml:id="_ysUNsmG">Study Study design (n) Wearable device Measurement Major findings Nagatomi et al 46 RCT (n=30) Fitbit Inspire (Fitbit, Inc) Daily steps The home-based CR program was a safe and effective approach that improved 6MWD and muscle strength in HF patients with frailty Peripheral artery disease Gardner et al 47 RCT (n=119) StepWatch 3 activity monitor (Cyma, Inc) Daily step counts and activity intensity The home-based exercise program had high adherence and similarly improved claudication measures compared with a standard supervised program GOALS study 48 RCT (n=194) Caltrac vertical accelerometer (muscle dynamics fitness network) Activity units The home-based exercise program with a cognitive behavioral intervention improved objective and subjective measures of PA HONOR study 49 RCT (n=200) Fitbit Zip (Fitbit, Inc) Daily step counts The home-based exercise program without onsite visits did not improve 6MWD compared with usual care LITE study 50 RCT (n=305) Unspecified accelerometer Activity units Low-intensity home-based exercise was significantly less effective than the high-intensity group for improving 6MWD Diabetes Beck et al 51 RCT (n=158) Dexcom G4 Platinum Glucose levels and amount of TIR In patients with type 2 diabetes on basal-bolus insulin, CGM significantly reduced hemoglobin A1c at 24 wk compared with usual care with an adjusted difference in mean change of -0.3%.</s><s xml:id="_d327E4e">There was high satisfaction and adherence to CGM use MOBILE study 52 RCT (n=175) Dexcom G6 Glucose levels and amount of TIR In primary care patients with type 2 diabetes on basal insulin only, the CGM group had significantly improved hemoglobin A1c at 8 mo (adjusted difference, 0.4%) compared with fingerstick testing FLASH-UK study 53 RCT (n=156) Freestyle Libre 2 Glucose levels and amount of TIR In patients with type 1 diabetes, intermittently scanned CGM with optional alerts improved hemoglobin A1c by 0.5% compared with fingerstick testing.</s><s xml:id="_Qy5JnvK">The CGM group had more TIR and lower burden of hypoglycemia 6MWD indicates 6-min walk distance; AC, anticoagulation; AF, atrial fibrillation; BEAT-HF, Better Effectiveness After Transition-Heart Failure; BP, blood pressure; CAD, coronary artery disease; CGM, continuous glucose monitoring; CR, cardiac rehabilitation; CV, cardiovascular; ENGAGE, Evaluation of the Novel Use of Gamification with Alternative Goal-Setting Experiences; EPACS, Early Prolonged Ambulatory Cardiac Monitoring in Stroke; GOALS, Group Oriented Arterial Leg Study; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; HONOR, Home-Based Monitored Exercise for Peripheral Artery Disease; HR, heart rate; LINK-HF, Multisensor Noninvasive Remote Monitoring for Prediction of Heart Failure Exacerbation; LITE, Low Intensity Exercise Intervention in Peripheral Artery Disease Study; MA, meta-analysis; ML, machine learning; mSToPS, mHealth Screening to Prevent Strokes; MVPA, moderate-to-vigorous physical activity; PA, physical activity; PPG, photoplethysmogram; PPV, positive predictive value; QOL, quality of life; RCT, randomized controlled trial; RR, respiratory rate; SEARCH-HF, Post-surgical Enhanced Monitoring for Cardiac Arrhythmias and Atrial Fibrillation; SR, systematic review; TIA, transient ischemic attack; TIM-HF, Telemedical Interventional Management in Patients With Heart Failure; TIR, time in range; and VO 2 , oxygen uptake.</s></p><p xml:id="_xGMwbcs"><s xml:id="_6q6GS6G">Table 2. Continued Downloaded from <ref type="url" target="http://ahajournals.org">http://ahajournals.org</ref> by on June 8, 2025 REVIEW Circulation Research.</s><s xml:id="_92mgE9J">2023;132:652-670.</s><s xml:id="_V7gzzYA">DOI: 10.1161/CIRCRESAHA.122.322389</s><s xml:id="_PxWnRnQ">March 3, 2023 659 Wearable Devices in Cardiovascular Medicine</s></p><p xml:id="_NacJzmg"><s xml:id="_k5ndZJC">of ongoing studies to identify the effective gamification elements for target populations.</s><s xml:id="_gJVrr3c">JITAIs are personalized interventions that integrate real-time information from wearable devices to deliver notifications at times that are most likely to impact behavior. <ref type="bibr" target="#b63">63</ref></s><s xml:id="_TQfgZ8e">For example, a JITAI promoting PA may be delivered when an individual is walking near a green space during leisure time as they are more likely to integrate the behavioral change during this time. <ref type="bibr" target="#b64">64</ref></s><s xml:id="_D8tBe6U">A systematic review of JITAIs demonstrated mixed results on PA and sedentary behavior; however, it is important to note that studies in this review were underpowered and only 6 studies were randomized. <ref type="bibr" target="#b64">64</ref></s><s xml:id="_3gS38WD">Effective JITAIs require the use of evidence-based behavioral change techniques and the delivery of notifications in a timely manner, but this may be lacking in some of the published studies.</s><s xml:id="_c4Bn3mQ">For example, the systematic review highlighted the lack of behavioral science evidence in the design of many JITAIs and identified one study where 43% of the intervention messages were not just-in-time. <ref type="bibr" target="#b64">64</ref></s><s xml:id="_jpepBtC">The mixed results likely arose due to the variations in the design and delivery of the JITAI in underpowered studies, which should be addressed as future studies aim to grow the supporting evidence base.</s><s xml:id="_rnhBxtj">Some important populations have been underrepresented in device-based PA studies including individuals of lower socioeconomic status and patients with mental illness. <ref type="bibr" target="#b1">2</ref> Adults from lower socioeconomic status have more difficulty increasing their PA levels compared with the general population. <ref type="bibr" target="#b31">31</ref></s><s xml:id="_J2yzUzb">This is a complex phenomenon with numerous contributing factors such as inadequate leisure time arising from increased occupational responsibilities or the inability to access a safe exercise environment. <ref type="bibr" target="#b65">65</ref></s><s xml:id="_z7xnzeg">The Evaluation of the Novel Use of Gamification with Alternative Goal-Setting Experiences (ENGAGE) study <ref type="bibr" target="#b31">31</ref> demonstrated that a novel gamification intervention with a wearable activity tracker significantly increased PA in economically disadvantaged adults with an atherosclerotic CVD condition or 10-year atherosclerotic CVD risk score ≥7.5% in Philadelphia, PA by using self-chosen goals (rather than assigned) that were implemented immediately (rather than gradually over an 8-week period).</s><s xml:id="_ZpSRMG2">For example, the individuals were either assigned a goal of 2000-step increase from baseline or they were able to select a goal between 1000 and 3000 steps above baseline with the flexibility to change their self-selected goal at any time.</s><s xml:id="_FcHMB8v">Future studies are needed to further investigate PA in geographically and socioeconomically diverse populations.</s></p><p xml:id="_Tvd8CV8"><s xml:id="_akC3bEr">Lastly, there is a need for device-based PA studies with longer follow-up to further characterize the impact of PA on clinical and psychosocial outcomes as the current studies may have inadequate follow-up to capture the physiologic benefits that emerge after consistent changes in activity.</s><s xml:id="_JMzA8DN">Additionally, the duration of the current studies may be too short to effectively build a new habit.</s><s xml:id="_vuGp2vb">While the necessary follow-up duration remains unclear based on the current body of evidence, this will be an important variable to investigate to guide the design of future studies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_EyYBKXS">Atrial Fibrillation</head><p xml:id="_HG5WxfX"><s xml:id="_s7wByrk">AF is associated with an increased risk of all-cause mortality and significant morbidity from stroke and HF. <ref type="bibr" target="#b66">66</ref></s><s xml:id="_tz4RqTh">odern wearables represent a practical and effective tool to screen for AF, with potential to reduce stroke and mortality rates if therapeutic anticoagulation is initiated in eligible individuals.</s></p><p xml:id="_9XEFQTU"><s xml:id="_H2uXCyx">The development of an adhesive single-lead ECG chest patch, such as the Zio patch (iRhythm Technologies, San Francisco, CA), improved the practicality of ambulatory cardiac monitoring as the patch was smaller and less burdensome than traditional Holter monitors. <ref type="bibr" target="#b3">4</ref></s><s xml:id="_4eSwjKC">n a large cohort study of 26 751 patients who wore the Zio patch for clinical indications, there was incremental diagnostic yield for all arrhythmia types beyond the first 48 hours of monitoring. <ref type="bibr" target="#b67">67</ref></s><s xml:id="_9Ewq4mb">The mHealth Screening to Prevent Strokes (mSToPS) study found that AF screening in asymptomatic, high-risk patients with an ECG patch compared with nonmonitored controls led to increased rates of new AF diagnosis and anticoagulation initiation, but they also had higher health care resource utilization (ie, cardiology or primary care clinic visits) at 1 year. <ref type="bibr" target="#b13">13</ref></s><s xml:id="_q4ZkVJr">The mSToPS group subsequently published follow-up data, and the individuals who underwent AF screening had a lower rate of clinical events at 3 years compared with routine care.</s><s xml:id="_PqAxZ9w">However, the impact of early AF diagnosis on these findings remains unclear due to the observational nature of the study. <ref type="bibr" target="#b68">68</ref></s><s xml:id="_9H8Txkf">Two large studies investigated the ability of an irregular pulse notification from a photoplethysmogram-enabled smartwatch or band to identify a new diagnosis of AF in a predominantly middleaged population. <ref type="bibr" target="#b33">33,</ref><ref type="bibr" target="#b34">34</ref></s><s xml:id="_aKp3KKt">These studies demonstrated a low prevalence of HR irregularity, and the diagnostic algorithms performed well with a positive predictive value of 0.84 to 0.92 for AF.</s><s xml:id="_nuT3YnG">Additionally, RCTs have demonstrated increased AF detection rates with continuous ambulatory ECG monitoring in specific high-risk patient populations (ie, cryptogenic stroke or postcardiac surgery). <ref type="bibr" target="#b35">35,</ref><ref type="bibr" target="#b36">36</ref></s><s xml:id="_HA6XrsS">here are important limitations with the existing body of literature, some of which are being addressed by ongoing studies.</s><s xml:id="_nkJ8ede">For example, it remains unclear whether improved AF detection will reduce hard clinical outcomes with an acceptable safety profile.</s><s xml:id="_VtDd99q">Future studies should also investigate whether wearable devices can be used to optimize an outpatient medication regimen in patients with an established diagnosis of AF, such as the uptitration of β-blockers or the addition of another antiarrhythmic medication if the patient has insufficient rate control.</s><s xml:id="_ZhHGsWh">Additionally, there are limited validation studies investigating the use of these devices</s></p><p xml:id="_ZUNzjE2"><s xml:id="_tdJvmTt">REVIEW 660 March 3, 2023 Circulation Research.</s><s xml:id="_x6XJjK2">2023;132:652-670.</s><s xml:id="_p29TnA9">DOI: 10.1161/CIRCRESAHA.122.322389</s><s xml:id="_gqJSGcY">Hughes et al Wearable Devices in Cardiovascular Medicine</s></p><p xml:id="_uMwzmtz"><s xml:id="_S6HKG9e">in clinical practice.</s><s xml:id="_V8F2Yk3">Current literature has raised concern about the accuracy of wearables for AF detection as some validation studies have found notably worse performance compared with industry-reported data. <ref type="bibr" target="#b69">69,</ref><ref type="bibr" target="#b70">70</ref></s><s xml:id="_edCDkGc">his highlights the need for rigorous, real-world validation studies in clinical settings.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_gB5CwcQ">Heart Failure</head><p xml:id="_gUxQ9xH"><s xml:id="_H7ekjrZ">Studies using wearable devices to improve HF management have reported mixed results.</s><s xml:id="_sYPdD6y">Several RCTs have assessed whether noninvasive telemonitoring interventions decrease HF readmissions or all-cause mortality.</s></p><p xml:id="_aAQ5jPR"><s xml:id="_Tm2k4Wz">Many of these studies used multifaceted telemonitoring interventions with home ECG devices, BP monitors, and weight scales along with increased provider follow-up.</s><s xml:id="_YhFmUuz">Telemonitoring in the Management of Heart Failure (TEMA-HF) study 1 <ref type="bibr" target="#b71">71</ref> and the Telemedical Interventional Management in Patients With Heart Failure (TIMHF) study 2 <ref type="bibr" target="#b40">40</ref> showed improved clinical outcomes while the TIM-HF <ref type="bibr" target="#b38">38</ref> and Better Effectiveness After Transition-Heart Failure (BEAT-HF) study <ref type="bibr" target="#b39">39</ref> studies did not improve all-cause mortality or readmission rates.</s><s xml:id="_CgmKpB9">It is difficult to evaluate the impact of wearable devices on clinical outcomes in these telemonitoring studies as the benefit may have been due to the extensive clinical follow-up rather than the use of wearable devices.</s></p><p xml:id="_hrbBwBh"><s xml:id="_nvMpCz3">The mixed results across studies likely stem from differences in the study population and significant variation in the telemonitoring interventions such as the devices used, follow-up frequency, study team composition (ie, general practitioners, cardiologists, and nurses), and intensity of intervention (ie, patient education, health coaching, and urgency/frequency of medication adjustments).</s><s xml:id="_Q499Zyy">The impact of the study cohort is seen in the TIM-HF <ref type="bibr" target="#b38">38</ref> and TIM-HF 2 <ref type="bibr" target="#b40">40</ref> studies as similar physicianled telemonitoring programs only yielded clinical benefit when applied to the well-defined HF population of TIM-HF 2 (ie, hospitalization in the past year and no major depression) compared with the broader TIM-HF study population (ie, patients with stable ambulatory HF).</s><s xml:id="_bBet69w">Two studies investigated whether an ML algorithm that utilizes continuous data from wearable devices can predict HF decompensation.</s><s xml:id="_h7kSfCg">The Multisensor Monitoring in Congestive Heart Failure (MUSIC) study <ref type="bibr" target="#b72">72</ref> developed and validated a personalized algorithm to predict acute decompensation in 543 patients with HF.</s><s xml:id="_CYzwYwE">The wearable chest patch continuously monitored HR, respiratory rate, activity, posture, and bioimpedance.</s><s xml:id="_ATCnKKs">The algorithm predicted HF decompensation with 63% sensitivity and 92% specificity in the validation cohort.</s><s xml:id="_d6uJNn9">However, the results of this study were limited as 42% of patients were excluded from statistical analyses, largely due to poor performance of the wearable device prototype.</s><s xml:id="_wGRGc4S">The Multisensor Non-invasive Remote Monitoring for Prediction of Heart Failure Exacerbation (LINK-HF) study <ref type="bibr" target="#b41">41</ref> is a multicenter, observational study of 100 patients who wore a chest patch that captured continuous ECG, accelerometry, impedance, and skin temperature.</s><s xml:id="_Mj75vkh">The ML algorithm used these data to predict impending HF hospitalization with 76% to 88% sensitivity and 85% specificity at a median time of 6.5 days before the admission.</s><s xml:id="_EGVxdAF">Since the clinical alerts preceded the hospitalization by ≈1 week, this may provide adequate time to make medication adjustments focused on preventing hospitalization.</s></p><p xml:id="_CQevSVV"><s xml:id="_vrkF8JT">Small studies with novel biomechanical sensors show promise in the management of patients with HF.</s><s xml:id="_EpRZEkj">Remote dielectric sensing (ReDS) uses electromagnetic energy technology in a wearable vest to measure lung fluid volume for assessment of the patient's volume status.</s><s xml:id="_gja427T">Two studies suggest that ReDS-guided management, such as diuretic adjustment, may reduce HF readmission rates. <ref type="bibr" target="#b73">73,</ref><ref type="bibr" target="#b74">74</ref></s><s xml:id="_K2HKUfA">n a prospective study of 50 patients hospitalized for acute decompensated HF, the use of daily ReDS measurements to optimize outpatient HF therapies during a 90-day follow-up period reduced HF readmission rates. <ref type="bibr" target="#b73">73</ref></s><s xml:id="_w5e7Etn"> retrospective cohort study of 220 patients who were seen for a follow-up clinic visit shortly after HF hospitalization demonstrated that patients who received pointof-care ReDS testing during the clinic visit had a lower 30-day cardiovascular readmission rate compared with patients who did not receive a ReDS assessment. <ref type="bibr" target="#b74">74</ref></s><s xml:id="_xjDUHFW">Seismocardiogram measures the local vibration of the chest wall that occurs during the cardiac cycle.</s><s xml:id="_6s3mgWt">When seismocardiogram was measured in the setting of submaximal exercise with the 6-minute walk test, this technology was able to differentiate between patients with decompensated and compensated HF. <ref type="bibr" target="#b15">15</ref> Wearable devices are also used as a research tool in several HF trials to measure outcomes, such as PA or sleep, in response to a pharmacologic intervention.</s><s xml:id="_xzvBVuj">The Nitrate's Effect on Activity Tolerance in Heart Failure with Preserved Ejection Fraction (NEAT-HFpEF) study tested the hypothesis that extended-release isosorbide mononitrate would improve daily activity levels, as measured by accelerometers, in patients with HF with preserved ejection fraction. <ref type="bibr" target="#b75">75</ref></s><s xml:id="_4SzkNkR">In this study, patients with HF with preserved ejection fraction who received isosorbide mononitrate had decreased activity levels compared with placebo.</s><s xml:id="_xxr6mGx">The AWAKE-HF study used wrist actigraphy to investigate the impact of sacubitril/valsartan on activity and sleep in patients with HF with reduced ejection fraction. <ref type="bibr" target="#b76">76,</ref><ref type="bibr" target="#b77">77</ref></s><s xml:id="_n9w4rpW">They hypothesized that sacubitril/valsartan would improve PA levels and sleep compared with enalapril, but the study found no differences in either of these actigraph-measured outcomes.</s><s xml:id="_XFvCd9C">Lastly, the HeartSleep Study used actigraph-measured sleep parameters, such as sleep efficiency and sleep duration, to demonstrate the sustained effects of cognitive behavioral therapy in patients with chronic HF and insomnia compared with a self-management program. <ref type="bibr" target="#b78">78</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_uU8wgyj">Downloaded</head><p xml:id="_A9qJ4F9"><s xml:id="_y2H2Cut">from <ref type="url" target="http://ahajournals.org">http://ahajournals.org</ref> by on June 8, 2025 REVIEW Circulation Research.</s><s xml:id="_CFAdBd7">2023;132:652-670.</s><s xml:id="_mzzTVbr">DOI: 10.1161/CIRCRESAHA.122.322389</s><s xml:id="_2g8ARQg">March 3, 2023 661 Wearable Devices in Cardiovascular Medicine</s></p><p xml:id="_uAF3c5x"><s xml:id="_q8BJnAT">In light of advancements in device technology and artificial intelligence (AI) capabilities, future studies should use wearable devices in large RCTs to further clarify the clinical utility of wearable devices in remote HF management.</s><s xml:id="_rRe9CaE">There is a wide range of potential clinical applications that warrant future investigation including innovative applications of novel sensors and ML algorithms, as well as the optimization of traditional HF therapies with existing consumer-grade wearables.</s><s xml:id="_dSCTuQc">For example, studies could evaluate whether notifications from wearable devices can improve HF outcomes through increased adherence to standard medications such as diuretics and guideline-directed medical therapy.</s><s xml:id="_gWhHVZH">Additionally, the HR and BP monitoring from wearable devices may provide clinicians with useful information to safely uptitrate guideline-directed medical therapy.</s><s xml:id="_kbRMvSK">Lastly, the existing body of evidence supports the ongoing use of wearable devices in research studies to assess PA and sleep outcomes, which are relevant measures in patients with HF.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_TzjqRcs">Cardiac Rehabilitation</head><p xml:id="_9ZeQgaf"><s xml:id="_VP6yNmh">Cardiac rehabilitation (CR) incorporates patient education, lifestyle modification, and exercise training for secondary prevention of cardiovascular conditions. <ref type="bibr" target="#b79">79</ref></s><s xml:id="_CVnnHFp">CR has been historically underutilized due to access and cost issues, so home-based CR programs were introduced to improve participation.</s><s xml:id="_SyzNXtW">The Telerehab II <ref type="bibr" target="#b42">42</ref> study was an RCT that added an 18-week PA telemonitoring intervention to conventional CR.</s><s xml:id="_WQvD2fX">The telemonitoring intervention utilized a triaxial accelerometer and weekly personalized automated feedback via email or text to encourage the patients to increase their step count by 10% each week.</s><s xml:id="_YRcxpHd">The intervention increased the patient's physical fitness (peak maximum oxygen uptake) and showed a trend toward fewer rehospitalizations compared with the standard CR group.</s><s xml:id="_p6afcJY">Several RCTs demonstrated that homebased and center-based CR similarly improved clinical outcomes. <ref type="bibr" target="#b79">79</ref></s><s xml:id="_YmeTAfr">For example, a randomized controlled noninferiority trial demonstrated that a telerehabilitation program that provided real-time, remote exercise monitoring with a chest-worn sensor and individualized coaching was similarly effective and reduced program delivery costs compared with center-based CR. <ref type="bibr" target="#b43">43</ref> The wearable device measured heart and respiratory rates, singlelead ECG, and accelerometry during the exercise training sessions, which were transmitted to a CR specialist in real time for review.</s><s xml:id="_phrJqnp">Based on the wearable data, the CR specialist provided real-time individualized coaching, feedback, and support during the exercise sessions.</s><s xml:id="_CsWssKZ">The SmartCare-CAD study <ref type="bibr" target="#b44">44,</ref><ref type="bibr" target="#b45">45</ref> evaluated the efficacy of a novel cardiac telerehabilitation intervention that focused on preventing relapse into a sedentary lifestyle compared with center-based CR.</s><s xml:id="_FyhMvAg">The intervention included 6 supervised sessions, home-based training with wearable devices, and weekly video meetings.</s><s xml:id="_wCpzagh">The study used both a wrist-worn HR monitor and a hip-worn triaxial accelerometer, which was uploaded for review and feedback by an exercise specialist during weekly video meetings for 3 months.</s><s xml:id="_q5xveuX">After 3 months, the weekly meetings stopped, but patients continued to upload data from their wearable devices on a weekly basis to identify when relapses occurred.</s><s xml:id="_VTZTDPR">Relapses were defined as nonadherence (ie, no data uploaded) or a 50% reduction in PA, and these prompted video consultations for additional coaching.</s><s xml:id="_CAhS5Af">The telerehabilitation program similarly improved PA and quality of life compared with center-based CR in this population of patients with low-risk CAD.</s></p><p xml:id="_B6ptNkf"><s xml:id="_7vVCeb2">Many of the existing studies used research-grade devices for PA monitoring, but recent studies have started to incorporate consumer-grade wearables.</s><s xml:id="_8F3ej4d">Nagatomi et al <ref type="bibr" target="#b46">46</ref> randomized 30 patients with HF with physical frailty to a home-based CR program with exercise and nutrition coaching via a Fitbit device.</s><s xml:id="_e3ju9eZ">The intervention improved 6-minute walk distance and muscle strength compared with standard care without a CR component.</s><s xml:id="_bcNzr5A">The body of evidence for CR with wearable devices continues to grow, and ongoing studies are investigating ways to maximize the durability of CR. <ref type="bibr" target="#b63">63</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_PzfstQE">Peripheral Artery Disease</head><p xml:id="_8rdxJYX"><s xml:id="_Yq9WDbC">The initial management for patients with symptomatic peripheral artery disease is a supervised exercise program to improve functional capacity and quality of life with guidelines supporting both center-and home-based exercise programs (class IIa recommendation). <ref type="bibr" target="#b80">80</ref></s><s xml:id="_hFAYdmX">Similar to CR, the center-based programs are underutilized due to access issues and the burden of traveling to the medical center on a regular basis, which highlights the importance of developing effective home-based programs.</s><s xml:id="_set34TJ">In a single-center RCT, a home-based exercise program with a StepWatch3 activity monitor improved claudication measures to a similar degree as a standard supervised program. <ref type="bibr" target="#b47">47</ref></s><s xml:id="_CkA4E26">The patients quantified their home exercise sessions with the step activity monitor, and the data were analyzed every 2 weeks by an exercise specialist to provide coaching and feedback during individualized meetings.</s><s xml:id="_TBmJF99">The Home Based Monitored Exercise for Peripheral Artery Disease (HONOR) study <ref type="bibr" target="#b49">49</ref> was the first RCT to investigate a home-based exercise program without any periodic medical center visits.</s><s xml:id="_UVTVyqV">Patients used a Fitbit Zip activity tracker to monitor their prescribed exercise regimen, and the data from the wearable device were available to the patient and their coach to facilitate discussions during their remote coaching sessions.</s><s xml:id="_RaX6DTn">The intervention did not improve the 6-minute walk distance, which suggests there may be a clinical benefit from intermittent visits to the medical center when patients are enrolled in the home-based programs.</s><s xml:id="_WHj3UQf">Notably, participants only adhered to 79% of the remote coaching sessions, which may have influenced the results as well.</s><s xml:id="_aKHrfk7">Recent studies have aimed to further refine the optimal design of homebased exercise programs.</s><s xml:id="_eNn8jyg">The Low Intensity Exercise Intervention in Peripheral Artery Disease (LITE) study <ref type="bibr" target="#b50">50</ref> randomized 305 patients to a home-based exercise program with varying intensities: low-intensity (does not induce ischemic leg symptoms), high-intensity (induces ischemic leg symptoms), or non-exercise controls.</s><s xml:id="_7Aget5Z">Participants wore an accelerometer to capture exercise intensity and were called weekly by a coach who used activity data to promote adherence.</s><s xml:id="_WusqFRk">The low-intensity program was significantly less effective than the high-intensity program, and there were no appreciable differences between the low-intensity and non-exercise control.</s><s xml:id="_Jvy3DdF">As the evidence supporting home-based exercise programs continues to grow, future studies should aim to determine the most effective design and intensity for home-based exercise programs that are reproducible, sustainable, and generalizable to large patient populations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_RpSX8eY">Coronary Artery Disease/Myocardial Infarction</head><p xml:id="_p9JpEfk"><s xml:id="_BqEV8uE">The recovery period after an acute myocardial infarction is associated with an increased risk of complications such as arrhythmias or need for readmission.</s><s xml:id="_mtXkh9Q">With the exception of CR (described above), the existing literature on wearable devices in the postmyocardial infarction recovery period is limited.</s><s xml:id="_dSRn3fs">Treskes et al <ref type="bibr" target="#b81">81</ref> evaluated the efficacy and feasibility of smart technology to control home BP in 200 patients after an acute type 1 myocardial infarction compared with usual care.</s><s xml:id="_2ynFkWc">The intervention utilized smartphone-compatible devices to measure daily single-lead ECGs, daily BP and weight, and continuous step measurements.</s><s xml:id="_hyU5PrC">Patients were contacted if their BP measurements exceeded prespecified thresholds or if the ECG identified a new arrhythmia.</s><s xml:id="_6E88mPS">The intervention also replaced some of the in-person follow-up visits with telemedicine visits.</s><s xml:id="_FQvnbKN">While this intervention was feasible and acceptable to patients, it did not improve BP control.</s><s xml:id="_TEmFDt8">Large prospective clinical trials are currently lacking for all aspects of CAD management.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_BNjrShh">Diabetes</head><p xml:id="_Rtw5H5h"><s xml:id="_GJqU53e">Patients with type 1 or type 2 diabetes have an increased risk of cardiovascular conditions such as CAD, stroke, peripheral artery disease, and HF.</s><s xml:id="_ZAjQTFa">CGM devices have several benefits as they can provide the patients with safety alerts (ie, hypoglycemia) and promote self-management of insulin dosing, while also providing clinicians with longitudinal data to optimize long-term glycemic control.</s><s xml:id="_55seutx">Evidence supports the use of CGM for patients with type 1 or type 2 diabetes to improve glycemic control.</s><s xml:id="_ytDcTm8">For example, in a multicenter RCT of 156 patients with type 1 diabetes on insulin infusions or multiple daily injections, the patients who intermittently scanned their CGM device (Freestyle Libre 2) with optional alarms for hyperglycemia or hypoglycemia had significantly lower hemoglobin A1c levels compared with the usual care group with traditional fingerstick testing. <ref type="bibr" target="#b53">53</ref></s><s xml:id="_gSZnBaz">A multicenter RCT of 158 patients with type 2 diabetes on basal-bolus insulin regimens demonstrated that CGM (Dexcom G4 Platinum) reduced hemoglobin A1c more effectively at 24 weeks compared with intermittent fingerstick readings. <ref type="bibr" target="#b51">51</ref></s><s xml:id="_Y4CmuhN">Similar results were seen in a cohort of 175 primary care patients with type 2 diabetes who were only managed with basal insulin, as the use of CGM (Dexcom G6) significantly reduced hemoglobin A1c levels at 8 months compared with intermittent fingerstick testing. <ref type="bibr" target="#b52">52</ref></s><s xml:id="_wHC2ng7">In each study, there were no statistically significant differences in the total daily insulin dose between the CGM and the fingerstick control groups.</s></p><p xml:id="_25cYawU"><s xml:id="_sjxJThF">While the ability for CGM to improve glycemic control is now well established, recent studies have started to investigate associations with clinical outcomes.</s><s xml:id="_hTnvxeD">CGM produces several measures of glycemic control, of which, time in range (TIR) likely represents a key metric in diabetes management.</s><s xml:id="_kakrTu8">In a prospective cohort study of 6225 patients with type 2 diabetes, <ref type="bibr" target="#b82">82</ref> TIR was inversely associated with long-term risk of all-cause and cardiovascular mortality.</s><s xml:id="_yjaas8G">TIR was assessed by CGM over a 72-hour period during a hospitalization, and patients were subsequently followed for a median follow-up of 6.9 years.</s><s xml:id="_7A2GCR4">In a cross-sectional study of 510 patients with diabetes and AF, patients underwent CGM for 72 hours after a hospitalization, and there was an inverse relationship between TIR and stroke risk. <ref type="bibr" target="#b83">83</ref></s><s xml:id="_2Vrf63Y">Future studies are needed to further investigate CGM metrics, such as TIR, and hard clinical outcomes.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_SMAhTdZ">CHALLENGES, OPPORTUNITIES, AND FUTURE DIRECTIONS</head><p xml:id="_f9sWA9N"><s xml:id="_AgJmQTV">This section summarizes many of the challenges that are currently hindering the widespread use of wearable devices in clinical care (Table <ref type="table" target="#tab_10">3</ref>), and we identify some short-and long-term solutions to transform the digital health landscape and improve cardiovascular care (Figure <ref type="figure" target="#fig_1">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_7hQ85Dq">Avoiding Unintended Health Disparities</head><p xml:id="_yasVvHT"><s xml:id="_gTTgu6g">The term digital divide describes the growing chasm between groups as a result of unequal access to digital technologies ranging from computers and the internet to smartphones and wearables.</s><s xml:id="_FGC6VtX">Groups who are most affected by the digital divide include people who are elderly, handicapped, of low socioeconomic status, or live in rural areas, with intersectionality often compounding the challenges.</s><s xml:id="_EnJxq6x">Apart from access, a lack of digital literacy can impede equitable implementation of digital technologies.</s><s xml:id="_EFUWuWB">Digital literacy describes an</s></p><p xml:id="_PREGNjj"><s xml:id="_5afhZBQ">Downloaded from <ref type="url" target="http://ahajournals.org">http://ahajournals.org</ref> by on June 8, 2025 REVIEW Circulation Research.</s><s xml:id="_ZZZm8mN">2023;132:652-670.</s><s xml:id="_D8rMfU9">DOI: 10.1161/CIRCRESAHA.122.322389</s><s xml:id="_YthAqK8">March 3, 2023 663 Wearable Devices in Cardiovascular Medicine individual's ability to use digital technology to access, understand, or communicate information through digital means.</s><s xml:id="_h5EsDyq">Given the rapidly changing technology landscape, including the continuous emergence of new types of devices, interfaces, and information, digital literacy remains a moving target.</s></p><p xml:id="_5pPMeKM"><s xml:id="_bqrJ2yN">Trends from the early stages of the COVID-19 pandemic highlighted significant inequities in access to telemedicine care.</s><s xml:id="_bbXnzYr">A cohort study of &gt;148 000 patients in primary care and subspecialty clinics demonstrated that older age, Asian race, and non-English speaking were associated with fewer telemedicine visits completed, and older age, female sex, Black race, Latinx ethnicity, and lower income were associated with less video use. <ref type="bibr" target="#b85">85</ref></s><s xml:id="_u45sj4V">Internet access is being increasingly recognized as a social determinant of health as this allows patients to participate in telemedicine visits, make appointments, and obtain test results. <ref type="bibr" target="#b86">86</ref></s><s xml:id="_x6GySDN">acial and ethnic minorities suffer from a higher prevalence of cardiometabolic conditions and associated mortality. <ref type="bibr" target="#b84">84</ref></s><s xml:id="_Y4JZJxt">These populations may stand to benefit from wearable device interventions to improve their cardiovascular health.</s><s xml:id="_v8w4EFx">However, there are several barriers that limit the efficacy of wearable devices in this population.</s><s xml:id="_hCtYcw5">There are currently a lack of non-English tools, <ref type="bibr" target="#b2">3</ref> limited culturally diverse mHealth interventions, <ref type="bibr" target="#b84">84</ref> and the social networks of these communities may not prioritize the adoption of wearable technology for health promotion. <ref type="bibr" target="#b87">87</ref></s><s xml:id="_ftjWk8p">Finally, the lower adoption of wearables in these groups may lead to their data being underrepresented in the large data sets used by ML models, which can further worsen disparities through data absenteeism. <ref type="bibr" target="#b88">88</ref></s><s xml:id="_HANdAHF">earable devices offer several potential benefits to older adults, but they are not widely used by this population.</s><s xml:id="_HMUWabX">In a survey of 1481 older adults, aged ≥65 years, only 17.5% of these individuals used a wearable device.</s><s xml:id="_RX4Hwqt">Of the older adults who used a wearable device, the majority (80%) were agreeable to sharing the data with health care providers. <ref type="bibr" target="#b89">89</ref></s><s xml:id="_ER9Zvtb">Some of the barriers to older adults using wearable devices include technology anxiety and resistance to change <ref type="bibr" target="#b90">90</ref> ; visual, hearing, and motor impairments with increased age <ref type="bibr" target="#b89">89</ref> ; and difficulty troubleshooting the device or user interface complexity. <ref type="bibr" target="#b91">91</ref></s><s xml:id="_55sUK4P">The current barriers illustrate that ease of use will be an important factor to increase the percentage of older adults who integrate wearable devices into their daily lives.</s></p><p xml:id="_B3SfFYT"><s xml:id="_g9dY5uW">The cost of wearable devices is quite variable depending on technological capabilities.</s><s xml:id="_2mtYEEF">Lower income may be an important driver of disproportionate use of wearable devices based on a survey of 4272 adults in which wearable use was 3× higher for individuals earning over $75 000 compared with individuals earning less than $30 000. <ref type="bibr" target="#b4">5</ref> Since adults with lower socioeconomic status experience greater difficulty increasing their PA compared with the general population, <ref type="bibr" target="#b31">31</ref> this warrants novel strategies to increase the accessibility of wearable devices in this population.</s></p><p xml:id="_bPvXHK8"><s xml:id="_UgBcPSq">As we move to expand the clinical use of wearable devices, we must recognize the existing inequities and work to design studies and clinical practices that achieve health equity rather than exacerbating current disparities.</s><s xml:id="_7G8U2n5">Efforts to address these disparities include improving broadband internet access, affordability of digital tools, language accessibility (ie, through translations), and form factor accessibility (ie, large text or voice-based agents for visual and hearing impairments, respectively).</s><s xml:id="_3BaDSSh">Recognizing internet access as a social determinant of health has been a critical first step, <ref type="bibr" target="#b86">86</ref> and efforts to advance broadband connectivity are already underway, for example, through the Connect2HealthFCC Task Force.</s><s xml:id="_a3dYJwm">Another effort by the US Department of Health and Human Services in 2022 awarded over $55M to Health Resources and Services Administration-funded health centers to enhance telehealth, digital patient tools, and health information technology to support underserved communities.</s><s xml:id="_df4pHZJ">Continued efforts to address the digital divide and digital literacy in the context of the evolving technology landscape will go a long way toward increasing the equitability of digital health.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_gaYgtPs">Design of Future Clinical Studies</head><p xml:id="_N9gXcDr"><s xml:id="_EzMqnzX">While the initial studies highlight the exciting potential for wearable devices, the current body of evidence still has several limitations.</s><s xml:id="_bEUhWMS">The generalizability of many existing studies is limited as there are several populations that are underrepresented including economically disadvantaged individuals, older adults, non-English speaking, and patients with mental illnesses.</s><s xml:id="_pqZK7cb">The reproducibility of studies is limited by a large degree of heterogeneity in the study design, interventions, and wearable devices used, which partially arises from the everchanging technological advancements and the abundance of available wearable devices.</s><s xml:id="_nknsrk3">Focus groups and pilot studies may be used to ensure that participant attitudes are incorporated into the study design to optimize adherence.</s><s xml:id="_C5SkQxY">Additionally, the future studies need to identify whether wearable devices and associated interventions lead to clinically meaningful results, which can be accomplished through long follow-up periods and hard clinical outcomes.</s><s xml:id="_FWjmxp3">Moving forward, we also need to evaluate the accuracy and validity of the wearable devices that are being used in these clinical studies through structured frameworks.</s><s xml:id="_ehk8bGT">Coravos et al <ref type="bibr" target="#b92">92</ref> proposed a robust framework for the assessment of the hardware and software components of wearable devices based on 5 key aspects: validation, security practices, data rights and governance, utility and usability, and economic feasibility.</s><s xml:id="_pQhCZp7">These evaluation frameworks will promote the use of safe and effective wearable devices in research studies and clinical practice, while identifying the devices that have suboptimal efficacy or the potential to cause harm.</s><s xml:id="_Jp95AcR">These frameworks may address some of the legal and ethical issues, such as privacy and data sharing policies and the lack of transparent wearable device algorithms, which must first be addressed before wearable devices can maximize their contributions to the Big Data movement designed to advance the field of cardiology. <ref type="bibr" target="#b93">93</ref></s><s xml:id="_hetquYp">astly, the FDA was able to provide the pharmaceutical industry with guidance and mandate large, long-term REVIEW Circulation Research.</s><s xml:id="_jvV9gXm">2023;132:652-670.</s><s xml:id="_h6Eq8QM">DOI: 10.1161/CIRCRESAHA.122.322389</s><s xml:id="_bkPPt2r">March 3, 2023 665</s></p><p xml:id="_T2YvYRb"><s xml:id="_4sb457S">Wearable Devices in Cardiovascular Medicine cardiovascular outcome trials for the development of medications for certain conditions, such as type 2 diabetes, <ref type="bibr" target="#b94">94</ref> but this may prove more challenging for the wearables field since a consumer-grade wearable may not be under FDA oversight with the existing regulatory policies.</s><s xml:id="_fGd23gQ">While these limitations and challenges are not easily overcome, a close collaboration between clinicians, scientists, industry, and community members, especially from historically underrepresented populations, may allow for the design of large reproducible and generalizable trials needed to strengthen the existing data.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_8FDcsSU">Integration of Wearables Into EHR</head><p xml:id="_RhaSuNx"><s xml:id="_ZZNc8Kj">Wearable device integration with EHR systems facilitates automatic transfer of real-time data on clinical measurements (ie, HR or blood glucose) and behavior measures (ie, PA or sleep) from a wearable device to an EHR system within the health care ecosystem.</s><s xml:id="_nQ7xJ9G">This integration of wearable data within the EHR is a promising approach to provide a more comprehensive view of patients' health as the clinical measurements may predict or identify a new diagnosis or help guide the management of a chronic condition.</s><s xml:id="_nN4b7Eu">Since patients can observe these clinical measurements in real time, it also fosters shared decisionmaking and improves patients' engagement in their care.</s></p><p xml:id="_CnHDsux"><s xml:id="_DDDZWE4">A recent study <ref type="bibr" target="#b55">55</ref> leveraged the longitudinal Fitbit and EHR data from the "All of Us" research program to examine the association between daily steps and incident disease that can occur across the entire human phenome.</s><s xml:id="_AqZ4TM6">This study illustrates the potential clinical value of linking wearables data to the EHR since it may provide valuable and actionable information to health care professionals and help advance personalized care.</s><s xml:id="_TyzwvTX">However, the integration of wearables into EHR systems is currently in the infancy stage given technical and privacy barriers. <ref type="bibr" target="#b95">95</ref></s><s xml:id="_pbzRaKW">Medical systems may not have sufficient technical infrastructure to support systems interoperability or to establish scalable workflows to protect patients' confidentiality.</s><s xml:id="_JcCnyuu">Another important consideration for integrating wearables into the EHR is to ensure that the patients consent to sharing their data.</s><s xml:id="_BRkUv78">This consent process should utilize clear documentation to avoid any misuse of a patient's personal health information. <ref type="bibr" target="#b96">96</ref></s><s xml:id="_KQbmeAn">Therefore, there is a need for additional policies to protect patient's confidentiality and minimize the risk of information misuse by third parties.</s><s xml:id="_d8pQ2VW">EHR systems must be able to manage the large amount of longitudinal data from wearable devices in order to utilize this information in a clinically meaningful manner.</s><s xml:id="_PrrDBB8">Clinicians will need to interpret the wearables data and tailor their recommendations to the individual patient, but it will be essential that EHR systems have the ability to identify the situations that warrant clinical intervention while minimizing false alarms to avoid an unintended increase in clinical workload.</s><s xml:id="_sQ9eABu">Lastly, there is a need for user-friendly interfaces to engage both the providers and the patients in the routine use of wearables in clinical practice.</s></p><p xml:id="_tkwvEv7"><s xml:id="_ReyPsbe">The integration of wearable data into the EHR will be a challenging endeavor that requires strong interdisciplinary teams to identify and implement solutions into clinical practice.</s><s xml:id="_xRE5SuN">Some of the initial steps that clinics and hospitals may take to enhance the integration of wearables include the development of educational resources for patients and clinicians, the identification of clinician champions, and to ensure that the clinical team has individuals capable of providing technological support. <ref type="bibr" target="#b97">97</ref></s><s xml:id="_uR3uysu">The educational resources and clinician champions should be transparent about the benefits and limitations of wearables data in the EHR and recognize that the information will likely need to be adapted as the use of wearables evolves over time.</s><s xml:id="_2kSwE8j">Managing the extensive data from wearables is critical, and solutions can be generated around FAIR guiding principles-findability, accessibility, interoperability, and reusability. <ref type="bibr" target="#b98">98</ref></s><s xml:id="_ESeYR84">For instance, ML and AI algorithms 99 may serve as potential solutions to identify the meaningful and actionable parameters for clinical care.</s><s xml:id="_MNPeFrG">A scoping review by Dinh-Le et al <ref type="bibr" target="#b95">95</ref> reported that ≈10 start-up companies are working with 16 health systems to develop workflows to meaningfully integrate wearables into EHR systems.</s><s xml:id="_k2sqnJJ">To further illustrate the value of multidisciplinary collaboration, a consortium of &gt;130 individuals from 60+ organizations (ie, industry, academia, policymakers, clinicians, and patients) established the Integration of CGM Data into the EHR project. <ref type="bibr">100</ref></s><s xml:id="_rMK5MuJ">The 2022 Integration of CGM Data into the EHR report discusses numerous practical considerations (ie, clinical workflows, team compositions, and EHR data displays), a template for a project implementation guide, and a list of formal recommendations from the Integration of CGM Data into the EHR steering committee.</s><s xml:id="_FZb66eV">The Integration of CGM Data into the EHR project aims to overcome many of the limitations hindering the integration of CGM data into the EHR, and this will likely serve as a useful framework for other wearable devices (ie, smartwatches) to build upon.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_gvYAGdn">Clinical Workflow</head><p xml:id="_Y54c7Jj"><s xml:id="_tKdy657">For wearable devices to reach its full potential, we need to expand the number of clinical staff who are trained and capable of managing the constant influx of data.</s><s xml:id="_yMdS3xu">This requires dedicated training on digital technology.</s><s xml:id="_Gh2zRT3">In the short term, the training may involve modules and seminars for all existing clinical staff followed by the creation of digital technology curriculum for nursing and medical schools to provide a sustainable, long-term approach.</s><s xml:id="_j6FkqMH">Additionally, it will be essential that we create strategies to allow these clinicians to easily identify actionable data while ignoring the noise that the abundant wearable data will inevitably generate.</s><s xml:id="_kMST4VE">By developing a common clinical platform that synthesizes information from wearables,</s></p><p xml:id="_6xmVsry"><s xml:id="_Qrr7cc3">REVIEW 666 March 3, 2023 Circulation Research.</s><s xml:id="_87w7Qb9">2023;132:652-670.</s><s xml:id="_aCSqXU6">DOI: 10.1161/CIRCRESAHA.122.322389</s><s xml:id="_EtZABhn">Hughes et al Wearable Devices in Cardiovascular Medicine</s></p><p xml:id="_nyYB7hd"><s xml:id="_9DVq6ud">EHR, and AI algorithms, we may be able to establish prespecified thresholds that identify the meaningful data that warrant clinical attention.</s><s xml:id="_PGcNy7H">This will certainly require close collaboration among clinicians, patients, and technology specialists, and these collaborative efforts may benefit from leveraging the expertise of existing companies that already provide implementation services and support for digital health technologies. <ref type="bibr" target="#b2">3</ref></s><s xml:id="_Mwc78ED">n response to the COVID-19 pandemic, the US FDA and Centers for Medicare and Medicaid Services modified some requirements for remote physiologic monitoring (RPM) to increase access to care and provide greater reimbursement flexibility for clinicians. 101,102</s><s xml:id="_d8rUG6D">RPM collects and analyzes physiologic data (ie, HR, weight, and pulse oximetry) from noninvasive medical devices, such as wearables, to guide the treatment of an acute or chronic condition.</s><s xml:id="_ayNcSgj">Currently, the reimbursement policies are more straightforward for certain aspects of RPM, such as vital signs, compared with variables such as PA. <ref type="bibr" target="#b4">5</ref> Current Procedural Terminology (CPT) codes include a 1-time reimbursement for the initial set-up of an RPM device (CPT 99453), data collection and interpretation (CPT 99091), and development/implementation of a treatment plan through interactive communication with the patient based on remotely collected data from devices, such as wearables (CPT 99457 and CPT 99458). <ref type="bibr">102</ref></s><s xml:id="_3fqXZS3">As we move beyond the current pandemic, we may consider expanded reimbursement policies to increase the clinical use of wearable devices if the growing body of scientific evidence proves to be beneficial and costeffective for the management of chronic conditions.</s><s xml:id="_UGr4ckj">For example, we may reach the point where evidence supports a novel reimbursement strategy for a clinician who reviews wearable data, such as PA, and prescribes wearable-guided interventions. <ref type="bibr" target="#b4">5</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_vwT9Jyv">Costs Associated With Clinical Use</head><p xml:id="_9W6rYk5"><s xml:id="_At2xnd3">In order to support the integration of wearable devices into routine clinical care, we must demonstrate that this is a cost-effective approach for patients and payers.</s><s xml:id="_eF77Kv5">For example, screening efforts that use wearables to identify new diagnoses, such as AF, must ensure that the screening improves clinical outcomes without increasing costs or harms that may arise from false positives or confirmatory follow-up testing. <ref type="bibr">103</ref></s><s xml:id="_26q8FDQ">Currently, the data on costeffectiveness of wearable interventions are limited.</s><s xml:id="_u6fHp3A">One recent systematic review examined the impact of wearables on health care outcomes in patients with chronic diseases, but only a small number of these studies examined costs. <ref type="bibr">104</ref></s><s xml:id="_JFk9xFb">A simulated model suggested that AF screening with wearable devices is cost-effective compared with no screening or traditional methods (ie, pulse palpation and 12-lead ECG), <ref type="bibr">103</ref> and an economic evaluation of a cardiac telerehabilitation program suggested that it was likely to be cost-effective compared with traditional center-based CR. <ref type="bibr" target="#b45">45</ref> As the existing body of evidence for wearables in cardiovascular medicine grows, it will be important for these studies to also publish cost analyses.</s><s xml:id="_cDAmnJH">The cost analyses should measure qualityadjusted life-years and incremental cost-effectiveness ratios as these variables will help guide future discussions about wearable technologies in clinical care.</s></p><p xml:id="_a53NSjx"><s xml:id="_xQgvvGg">Many of the key stakeholders have already demonstrated a commitment to promote a healthy lifestyle as health insurance companies offer incentive programs for healthy behaviors and employers provide workplace wellness programs.</s><s xml:id="_zCTXjuY">Wearable devices are frequently incorporated into these incentive or wellness programs.</s><s xml:id="_3xXUD2e">For example, Fitbit Health Solutions has already established programs to work with employers, health plans, and health systems to encourage PA, sleep, nutrition, and stress management.</s><s xml:id="_ncHC783">Additionally, policymakers have demonstrated a willingness to modify reimbursement policies, such as RPM reimbursement during the COVID-19 pandemic, when needed to support new avenues of health care delivery.</s><s xml:id="_A5XZ9pb">Similarly, Medicare and private health insurance plans now provide coverage for CGM devices for patients with type 1 and type 2 diabetes, so the payers may embrace a similar approach toward other wearable devices (ie, smartwatches) if the growing body of evidence demonstrates long-term benefits.</s><s xml:id="_rctHcqT">Lastly, all of these stakeholders will play a pivotal role in establishing the necessary infrastructure and payment models to overcome the initial start-up costs associated with integrating new wearable devices into clinical care in order to achieve the potential long-term benefits and decreased health care costs that wearables may offer.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9EYptGh">Data Accuracy/Validity</head><p xml:id="_2ezZMYG"><s xml:id="_PdvYkrz">Accelerometry devices such Actigraph and ActivPal are being increasingly used in research to quantify clinical measurements such as activity, sedentary behavior, or sleep.</s><s xml:id="_BxqA2mw">In addition, these devices are also being used to assess the validity and reliability of consumer-grade wearables. 105-107</s><s xml:id="_N239SkH">However, as hardware, software, and algorithmic properties of wearables continue to evolve, the number of wearables available in the market will also continue to grow.</s><s xml:id="_xuu9JKX">In turn, there may be potential risks related to data accuracy and validation. <ref type="bibr" target="#b92">92,</ref><ref type="bibr">108</ref></s><s xml:id="_GsbnTCf">Since consumer-grade wearables are not under FDA oversight, there is no regulatory agency surveying their accuracy.</s><s xml:id="_tC9Ypuf">Additionally, algorithms used for wearables are often not open sourced.</s><s xml:id="_67SjtXj">Given the lack of transparency in the AI algorithms and concerns about inaccurate data from unregulated devices, key challenges remain for health care professionals to interpret findings, such as alarms for AF, which hinder the widespread adoption of wearables in health care settings.</s><s xml:id="_eafdZ26">Data Security/Privacy AI algorithms rely heavily on personal data for their decision-making process, but the software and hardware used in these systems may have security vulnerabilities that could result in the theft of personal information.</s><s xml:id="_zrz6cxT">For that reason, significant effort is required to maintain the privacy and security of personal and identifiable data.</s><s xml:id="_v8BQGEd">We must also limit the number of individuals who have access to the raw identifiable data.</s><s xml:id="_awguRuk">Federated learning is a newer technique in AI that allows for a decentralized approach to training algorithms, thus addressing issues related to data safety and privacy. <ref type="bibr">109</ref></s><s xml:id="_gn23qXN">Unlike traditional methods, which involve centralizing data from multiple sources to train an algorithm, federated learning trains the algorithm locally on devices or servers, without sharing any data.</s></p><p xml:id="_8b3gsAZ"><s xml:id="_pwAJ9Qp">Instead, only the model parameters are shared and optimized through iteration.</s><s xml:id="_Zmeyv45">This approach keeps data safe and private by not sharing it.</s><s xml:id="_aw2uSU2">Finally, data ownership is an ongoing issue, which may result in unauthorized sharing of user data without explicit and prior approval.</s></p><p xml:id="_Sqswuem"><s xml:id="_pFqK6qt">Artificial Intelligence/Machine Learning AI and ML technologies are faced with various challenges such as fairness and bias, transparency and accountability, and data drift.</s><s xml:id="_xJZrAYb">These can occur when data and algorithms reflect, reinforce, or perpetuate biases or when the data used to train AI are incomplete or inherently biased, which can lead to further disparities and biases, particularly in underserved and underrepresented communities.</s><s xml:id="_XfK7cZE">Additionally, some models may be more accurate but opaque (ie, complex nonlinear models over simple linear models), making it difficult to understand how the algorithm reached its conclusions.</s><s xml:id="_J784dzt">This can be particularly problematic in health care, as it can affect a clinician's medical decision-making and a patient's treatment.</s><s xml:id="_2aPmn5m">Lastly, AI and ML algorithms often assume that data from the past will be representative of future data, which is not always the case in real-world settings, causing changes in the data to affect the model's behavior and accuracy.</s><s xml:id="_mTSjtUN">Although some ML, particularly DL, algorithms can outperform humans in certain tasks, such as detecting arrhythmias from ECG data 110 or diagnosing CVDs from radiology images, 111 AI technologies are more effective when used to augment rather than replace human capabilities.</s><s xml:id="_2vqj8jF">Additionally, AI can reduce human errors, enhance knowledge capacity, and save time previously spent on repetitive tasks.</s><s xml:id="_jncbwKK">However, it is important that we recognize both the exciting potential and the challenges and concerns of AI/ML as we apply these tools to health care. <ref type="bibr">112</ref></s><s xml:id="_cUqEH7X">As technological advancements in wearable sensor hardware and AI algorithms accelerate personalized medicine, care should be taken to ensure that these advancements do not worsen health-related disparities or create new inequities in care or health-related outcomes.</s><s xml:id="_KDbqsmw">Future research in this field should address equity and fairness of the development and application of AI in cardiovascular medicine, as well as the interpretability and generalizability of AI models. <ref type="bibr">113</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_pGgKfqt">CONCLUSIONS</head><p xml:id="_DvVb8kW"><s xml:id="_qtXDNNe">Wearable devices have the potential to revolutionize the prevention, diagnosis, and management of cardiovascular conditions.</s><s xml:id="_PH365bP">While patients frequently use wearable devices in their everyday lives, there remain several challenges that prevent the widespread integration of wearable technologies in clinical practice.</s><s xml:id="_hBj79qp">A collaborative, multidisciplinary approach with patients, clinicians, scientists, policymakers, and industry leaders will be needed to transform the digital health landscape and allow wearable devices to achieve their full clinical benefit.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p xml:id="_aNhFkVq"><s xml:id="_eXqVsQh">Figure 1.</s><s xml:id="_k7GCP5r">Overview of wearable devices.</s><s xml:id="_PJ5QpXs">A, Common sensor modalities utilized by wearable devices to generate physiologic measurements.</s><s xml:id="_hqjuj9S">B, Key physiologic measures, sensors, and potential clinical applications in cardiovascular medicine.</s><s xml:id="_b4j5jdC">CGM indicates continuous glucose monitoring; CVD, cardiovascular disease; GPS, global positioning system; HF, heart failure; MI, myocardial infarction; and PAD, peripheral artery disease.</s><s xml:id="_qSy9Wjv">*CGM devices use biochemical sensors to measure glucose levels and have important clinical applications for type 1 and 2 diabetes.</s><s xml:id="_VuanbHs">However, they are difficult to integrate into consumergrade wearables and are usually a stand-alone device.</s></p></div></figDesc><graphic coords="3,56.70,66.00,471.60,519.13" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p xml:id="_fEZqPSt"><s xml:id="_zYT7dG5">Figure 2. Short-and long-term road map to increase the use of wearable devices in clinical care.</s><s xml:id="_BVDxd6Z">ACS indicates acute coronary syndrome; AI, artificial intelligence; CAD, coronary artery disease; CV, cardiovascular; EHR, electronic health record; HIPAA, Health Insurance Portability and Accountability Act; IEEE, Institute of Electrical and Electronics Engineers; ML, machine learning; and RCT, randomized controlled trial.</s><s xml:id="_zPgBxTz">Downloaded from http://ahajournals.org by on June 8, 2025</s></p></div></figDesc><graphic coords="13,56.70,66.00,471.60,357.62" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><figDesc><div><p xml:id="_rPG5HXu"><s xml:id="_zn3S5SP">Downloaded from http://ahajournals.org by on June 8, 2025 REVIEW Circulation Research.</s><s xml:id="_FQUsww6">2023;132:652-670.</s><s xml:id="_GhY6VVJ">DOI: 10.1161/CIRCRESAHA.122.322389</s><s xml:id="_HDBBtPx">March 3, 2023 667 Wearable Devices in Cardiovascular Medicine</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_10"><head>Table 3 . Advantages and Challenges Associated With Wearable Devices in Cardiovascular Medicine: Patient and Health Care Provider Perspectives</head><label>3</label><figDesc><div><p><s xml:id="_d2vCU2c">84fficulty navigating the wearable device technology; exacerbated by cognitive, visual, or hearing impairments; poor understanding of the device's clinical role and inability to contextualize clinical significance of measurements; cost of device/software; inconsistent internet access; concern for data security; social isolation by decreasing in-person visits; lack of culturally diverse interventions84; lack of non-English resources</s></p></div></figDesc><table><row><cell></cell><cell>Advantages</cell><cell>Challenges</cell></row><row><cell>Patient</cell><cell>Active role in monitoring and managing chronic</cell><cell></cell></row><row><cell>perspectives</cell><cell>conditions; promotion of healthy lifestyle choices;</cell><cell></cell></row><row><cell></cell><cell>telemonitoring may reduce the number of office</cell><cell></cell></row><row><cell></cell><cell>visits, travel, and time commitment; increased</cell><cell></cell></row><row><cell></cell><cell>screening and earlier detection of disease; sense</cell><cell></cell></row><row><cell></cell><cell>of safety from continuous monitoring</cell><cell></cell></row><row><cell>Health care</cell><cell>Improved screening and management of</cell><cell>Insufficient clinical infrastructure and staff to handle wearables data; wearable use may be</cell></row><row><cell>provider</cell><cell>cardiac conditions; earlier detection of clinical</cell><cell>patient initiated, though providers are asked to interpret findings and provide guidance;</cell></row><row><cell>perspectives</cell><cell>decompensation that may be amenable to</cell><cell>integration of wearables data into EHR; lack of standardized reimbursement policies; need</cell></row><row><cell></cell><cell>intervention to prevent hospitalization; objective</cell><cell>for large randomized controlled trials to build supporting evidence to define meaningful</cell></row><row><cell></cell><cell>assessment of patient adherence to exercise</cell><cell>use criteria and clinical guidelines; constantly changing technology and poorly defined</cell></row><row><cell></cell><cell>or medication regimen; additional data for</cell><cell>regulatory oversight; concerns about device accuracy and validity; data privacy and</cell></row><row><cell></cell><cell>telemedicine visits</cell><cell>medicolegal concerns; concerns about potentially creating a new health disparity</cell></row><row><cell cols="2">EHR indicates electronic health record.</cell><cell></cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_b7QdA6N"><s xml:id="_WkB4Wmc">Downloaded from http://ahajournals.org by onJune 8, 2025</s></p></note>
		</body>
		<back>

			<div type="funding">
<div><head xml:id="_Wzz7jeU">Sources of Funding</head><p xml:id="_eFctDnD"><s xml:id="_gjZebMD">This work was supported by research grants from the <rs type="funder">Department of Health and Human Services (HHS)/National Institute of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI)</rs> (<rs type="grantNumber">R61 HL158941</rs>), <rs type="funder">HHS/FDA</rs> (<rs type="grantNumber">R01 FD007627</rs>), <rs type="funder">HHS/NIH/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)/DEM</rs> (<rs type="grantNumber">R01 DK124845</rs>), <rs type="funder">HHS/NIH/NHLBI</rs> (<rs type="grantNumber">R38 HL167237-01</rs>), and <rs type="funder">American Heart Association (AHA)</rs> (<rs type="grantNumber">3 POST 1025599</rs>).</s></p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_HyHAz9Q">
					<idno type="grant-number">R61 HL158941</idno>
				</org>
				<org type="funding" xml:id="_weRXUHv">
					<idno type="grant-number">R01 FD007627</idno>
				</org>
				<org type="funding" xml:id="_SSagNRj">
					<idno type="grant-number">R01 DK124845</idno>
				</org>
				<org type="funding" xml:id="_vvG84p5">
					<idno type="grant-number">R38 HL167237-01</idno>
				</org>
				<org type="funding" xml:id="_HsMhzBk">
					<idno type="grant-number">3 POST 1025599</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_cf4RAgj">REVIEW</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_qHKzvnm">REVIEW</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main" xml:id="_bjj2jXg">Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-forpurpose for Biometric Monitoring Technologies (BioMeTs)</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Goldsack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Coravos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Bakker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Dowling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fitzer-Attas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Godfrey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Godino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gujar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Izmailova</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41746-020-0260-4</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4cpQS8b">NPJ Digit Med</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">55</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Goldsack JC, Coravos A, Bakker JP, Bent B, Dowling AV, Fitzer-Attas C, Godfrey A, Godino JG, Gujar N, Izmailova E, et al. Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for- purpose for Biometric Monitoring Technologies (BioMeTs). NPJ Digit Med. 2020;3:55. doi: 10.1038/s41746-020-0260-4</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_3XXGSZx">Effectiveness of wearable activity trackers to increase physical activity and improve health: a systematic review of systematic reviews and meta-analyses</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ferguson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Olds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Curtis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Blake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Crozier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dankiw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dumuid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kasai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Virgara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<idno type="DOI">10.1016/s2589-7500(22)00111-x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VM2VwTB">Lancet Digit Health</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="615" to="e626" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ferguson T, Olds T, Curtis R, Blake H, Crozier AJ, Dankiw K, Dumuid D, Kasai D, O&apos;Connor E, Virgara R, et al. Effectiveness of wearable activity trackers to increase physical activity and improve health: a system- atic review of systematic reviews and meta-analyses. Lancet Digit Health. 2022;4:e615-e626. doi: 10.1016/s2589-7500(22)00111-x</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_sjdeBCC">Wearables, telemedicine, and artificial intelligence in arrhythmias and heart failure: proceedings of the European Society of Cardiology: cardiovascular round table</title>
		<author>
			<persName><forename type="first">C</forename><surname>Leclercq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Witt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hindricks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Katra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Albert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Belliger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Cowie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Deneke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Haschemi</surname></persName>
		</author>
		<idno type="DOI">10.1093/europace/euac052</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8yxe9gY">Europace</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1372" to="1383" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Leclercq C, Witt H, Hindricks G, Katra RP, Albert D, Belliger A, Cowie MR, Deneke T, Friedman P, Haschemi M, et al. Wearables, telemedicine, and artificial intelligence in arrhythmias and heart failure: proceedings of the European Society of Cardiology: cardiovascular round table. Europace. 2022;24:1372-1383. doi: 10.1093/europace/euac052</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_BxmTVfq">Wearable devices for ambulatory cardiac monitoring: JACC state-of-the-art review</title>
		<author>
			<persName><forename type="first">F</forename><surname>Sana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Isselbacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Heist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Pathik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Armoundas</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacc.2020.01.046</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZP6TMgJ">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="1582" to="1592" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sana F, Isselbacher EM, Singh JP, Heist EK, Pathik B, Armoundas AA. Wear- able devices for ambulatory cardiac monitoring: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75:1582-1592. doi: 10.1016/j.jacc.2020.01.046</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_EWBBKWb">Smart wearable devices in cardiovascular care: where we are and how to move forward</title>
		<author>
			<persName><forename type="first">K</forename><surname>Bayoumy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gaber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Elshafeey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Mhaimeed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Dineen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Marvel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Muse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Turakhia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Tarakji</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41569-021-00522-7</idno>
		<idno>DOI: 10.1161/CIRCRESAHA.122.322389</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_65CUARh">Circulation Research</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="652" to="670" />
			<date type="published" when="2021">2021. 2023</date>
		</imprint>
	</monogr>
	<note>Nat Rev Cardiol</note>
	<note type="raw_reference">Bayoumy K, Gaber M, Elshafeey A, Mhaimeed O, Dineen EH, Marvel FA, Martin SS, Muse ED, Turakhia MP, Tarakji KG, et al. Smart wearable devices in cardiovascular care: where we are and how to move forward. Nat Rev Cardiol. 2021;18:581-599. doi: 10.1038/s41569-021-00522-7 Circulation Research. 2023;132:652-670. DOI: 10.1161/CIRCRESAHA.122.322389</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title/>
		<author>
			<persName><surname>Hughes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wa77kQ3">Cardiovascular Medicine</title>
		<imprint/>
	</monogr>
	<note type="raw_reference">Hughes et al Wearable Devices in Cardiovascular Medicine</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_MMPvxxE">Integration of novel monitoring devices with machine learning technology for scalable cardiovascular management</title>
		<author>
			<persName><forename type="first">C</forename><surname>Krittanawong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Rogers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Turakhia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Halperin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Narayan</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41569-020-00445-9</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VnQtw2K">Nat Rev Cardiol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="75" to="91" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Krittanawong C, Rogers AJ, Johnson KW, Wang Z, Turakhia MP, Halperin JL, Narayan SM. Integration of novel monitoring devices with machine learning technology for scalable cardiovascular management. Nat Rev Car- diol. 2021;18:75-91. doi: 10.1038/s41569-020-00445-9</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_NxAhR6r">Mobile health technologies in cardiopulmonary disease</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">E</forename><surname>Mackinnon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Brittain</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.chest.2019.10.015</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3hFXdCY">Chest</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="654" to="664" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">MacKinnon GE, Brittain EL. Mobile health technologies in cardiopulmonary disease. Chest. 2020;157:654-664. doi: 10.1016/j.chest.2019.10.015</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_cEcbUQs">A review of accelerometry-based wearable motion detectors for physical activity monitoring</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">L</forename><surname>Hsu</surname></persName>
		</author>
		<idno type="DOI">10.3390/s100807772</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jxuXw22">Sensors</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="7772" to="7788" />
			<date type="published" when="2010">2010</date>
			<pubPlace>Basel)</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Yang CC, Hsu YL. A review of accelerometry-based wearable motion detec- tors for physical activity monitoring. Sensors (Basel). 2010;10:7772-7788. doi: 10.3390/s100807772</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_EKa2s7u">Classification of decompensated heart failure from clinical and home ballistocardiography</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">B</forename><surname>Aydemir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nagesh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mmh</forename><surname>Shandhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Etemadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Heller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">T</forename><surname>Inan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Rehg</surname></persName>
		</author>
		<idno type="DOI">10.1109/tbme.2019.2935619</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_bRQw7qU">IEEE Trans Biomed Eng</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="1303" to="1313" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Aydemir VB, Nagesh S, Shandhi MMH, Fan J, Klein L, Etemadi M, Heller JA, Inan OT, Rehg JM. Classification of decompensated heart failure from clini- cal and home ballistocardiography. IEEE Trans Biomed Eng. 2020;67:1303- 1313. doi: 10.1109/tbme.2019.2935619</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_yBabxEa">A review on wearable photoplethysmography sensors and their potential future applications in health care</title>
		<author>
			<persName><forename type="first">D</forename><surname>Castaneda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Esparza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ghamari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Soltanpur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nazeran</surname></persName>
		</author>
		<idno type="DOI">10.15406/ijbsbe.2018.04.00125</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_M4tMBXS">Int J Biosens Bioelectron</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="195" to="202" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Castaneda D, Esparza A, Ghamari M, Soltanpur C, Nazeran H. A review on wearable photoplethysmography sensors and their potential future appli- cations in health care. Int J Biosens Bioelectron. 2018;4:195-202. doi: 10.15406/ijbsbe.2018.04.00125</note>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title level="m" type="main" xml:id="_cvzzrBk">Photoplethysmography: Technology, Signal Analysis and Applications</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Kyriacou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Allen</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2021">2021</date>
			<publisher>Academic Press</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Kyriacou PA, Allen J. Photoplethysmography: Technology, Signal Analysis and Applications: Academic Press; 2021.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_A7dcnMY">Fundamentals of electrocardiography interpretation</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Becker</surname></persName>
		</author>
		<idno type="DOI">10.2344/0003-3006(2006)53[53:foei]2.0.co;2</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uC3kJB4">Anesth Prog</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="53" to="64" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Becker DE. Fundamentals of electrocardiography interpretation. Anesth Prog. 2006;53:53-64. doi: 10.2344/0003-3006(2006)53[53:foei]2.0.co;2</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_H86FBmF">Effect of a homebased wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation: the mSToPS randomized clinical trial</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Steinhubl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Waalen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Ariniello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Ebner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Baca-Motes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Felicione</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sarich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Topol</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2018.8102</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_g8cRgfJ">JAMA</title>
		<imprint>
			<biblScope unit="volume">320</biblScope>
			<biblScope unit="page" from="146" to="155" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Steinhubl SR, Waalen J, Edwards AM, Ariniello LM, Mehta RR, Ebner GS, Carter C, Baca-Motes K, Felicione E, Sarich T, Topol EJ. Effect of a home- based wearable continuous ECG monitoring patch on detection of undi- agnosed atrial fibrillation: the mSToPS randomized clinical trial. JAMA. 2018;320:146-155. doi: 10.1001/jama.2018.8102</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_dtJ8XV4">Ballistocardiography and seismocardiography: a review of recent advances</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">T</forename><surname>Inan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Migeotte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Etemadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tavakolian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Casanella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zanetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Funtova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Prisk</surname></persName>
		</author>
		<idno type="DOI">10.1109/jbhi.2014.2361732</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_P6QDzSz">IEEE J Biomed Health Inform</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1414" to="1427" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Inan OT, Migeotte PF, Park KS, Etemadi M, Tavakolian K, Casanella R, Zanetti J, Tank J, Funtova I, Prisk GK, et al. Ballistocardiography and seis- mocardiography: a review of recent advances. IEEE J Biomed Health Inform. 2015;19:1414-1427. doi: 10.1109/JBHI.2014.2361732</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_6eQ6sBA">Novel wearable seismocardiography and machine learning algorithms can assess clinical status of heart failure patients</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">T</forename><surname>Inan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Baran Pouyan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Q</forename><surname>Javaid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dowling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Etemadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dorier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Heller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">O</forename><surname>Bicen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Marco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
		<idno type="DOI">10.1161/circheartfailure.117.004313</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_nAH8mSc">Circ Heart Fail</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">4313</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Inan OT, Baran Pouyan M, Javaid AQ, Dowling S, Etemadi M, Dorier A, Heller JA, Bicen AO, Roy S, De Marco T, et al. Novel wearable seismo- cardiography and machine learning algorithms can assess clinical sta- tus of heart failure patients. Circ Heart Fail. 2018;11:e004313. doi: 10.1161/CIRCHEARTFAILURE.117.004313</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_kZQH7YD">International consensus on use of continuous glucose monitoring</title>
		<author>
			<persName><forename type="first">T</forename><surname>Danne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nimri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Battelino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Bergenstal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Close</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Devries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Garg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Heinemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Amiel</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc17-1600</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_A6BQEE6">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1631" to="1640" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Danne T, Nimri R, Battelino T, Bergenstal RM, Close KL, DeVries JH, Garg S, Heinemann L, Hirsch I, Amiel SA, et al. International consensus on use of continuous glucose monitoring. Diabetes Care. 2017;40:1631-1640. doi: 10.2337/dc17-1600</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_NVfCQPg">Wearable patch-based estimation of oxygen uptake and assessment of clinical status during cardiopulmonary exercise testing in patients with heart failure</title>
		<author>
			<persName><forename type="first">Mmh</forename><surname>Shandhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hersek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fan</forename><forename type="middle">J</forename><surname>Sander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Marco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Heller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Etemadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Inan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">T</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.cardfail.2020.05.014</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_m9HnkK7">J Card Fail</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="948" to="958" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shandhi MMH, Hersek S, Fan J, Sander E, De Marco T, Heller JA, Etemadi M, Klein L, Inan OT. Wearable patch-based estimation of oxygen uptake and assessment of clinical status during cardiopulmonary exercise testing in patients with heart failure. J Card Fail. 2020;26:948-958. doi: 10.1016/j.cardfail.2020.05.014</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_qDEMY7E">Wearable sensors enable personalized predictions of clinical laboratory measurements</title>
		<author>
			<persName><forename type="first">J</forename><surname>Dunn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kidzinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Runge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Witt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Hicks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Schüssler-Fiorenza</forename><surname>Rose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Bahmani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Delp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Hastie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
		<idno type="DOI">10.1038/s41591-021-01339-0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CdSnxHn">Nat Med</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="1105" to="1112" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dunn J, Kidzinski L, Runge R, Witt D, Hicks JL, Schüssler-Fiorenza Rose SM, Li X, Bahmani A, Delp SL, Hastie T, et al. Wearable sensors enable personalized predictions of clinical laboratory measurements. Nat Med. 2021;27:1105-1112. doi: 10.1038/s41591-021-01339-0</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_f4pXnan">Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Hannun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rajpurkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Haghpanahi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Tison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bourn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Turakhia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Ng</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41591-018-0268-3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HKaWzkJ">Nat Med</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="65" to="69" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hannun AY, Rajpurkar P, Haghpanahi M, Tison GH, Bourn C, Turakhia MP, Ng AY. Cardiologist-level arrhythmia detection and classification in ambula- tory electrocardiograms using a deep neural network. Nat Med. 2019;25:65- 69. doi: 10.1038/s41591-018-0268-3</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_2kuNqGH">Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram</title>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">I</forename><surname>Attia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kapa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lopez-Jimenez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Mckie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Ladewig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Satam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Pellikka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Enriquez-Sarano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Noseworthy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Munger</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41591-018-0240-2</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jWUrh5P">Nat Med</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="70" to="74" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Attia ZI, Kapa S, Lopez-Jimenez F, McKie PM, Ladewig DJ, Satam G, Pellikka PA, Enriquez-Sarano M, Noseworthy PA, Munger TM, et al. Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram. Nat Med. 2019;25:70-74. doi: 10.1038/s41591-018-0240-2</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_Y96397P">Machine learning prediction in cardiovascular diseases: a meta-analysis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Krittanawong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Huh</forename><surname>Virk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bangalore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pinotti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kaplin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Narasimhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kitai</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41598-020-72685-1</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_RfB8Kqd">Sci Rep</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">16057</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Krittanawong C, Virk HUH, Bangalore S, Wang Z, Johnson KW, Pinotti R, Zhang H, Kaplin S, Narasimhan B, Kitai T, et al. Machine learning prediction in cardiovascular diseases: a meta-analysis. Sci Rep. 2020;10:16057. doi: 10.1038/s41598-020-72685-1</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_BFCr9kP">DeepHeart: semi-supervised sequence learning for cardiovascular risk prediction</title>
		<author>
			<persName><forename type="first">B</forename><surname>Ballinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hsieh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sohoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">H</forename><surname>Tison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Marcus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Sanchez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Maguire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Olgin</surname></persName>
		</author>
		<idno type="DOI">10.1609/aaai.v32i1.11891</idno>
	</analytic>
	<monogr>
		<title level="m" xml:id="_YJQe48f">Thirty-Second AAAI Conference on Artificial Intelligence</title>
		<imprint>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ballinger B, Hsieh J, Singh A, Sohoni N, Wang J, Tison GH, Marcus GM, Sanchez JM, Maguire C, Olgin JE. DeepHeart: semi-supervised sequence learning for cardiovascular risk prediction. Thirty-Second AAAI Conference on Artificial Intelligence. 2018.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_Fzm74HH">Estimation of changes in intracardiac hemodynamics using wearable seismocardiography and machine learning in patients with heart failure: a feasibility study</title>
		<author>
			<persName><forename type="first">Mmh</forename><surname>Shandhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Heller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Etemadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">T</forename><surname>Inan</surname></persName>
		</author>
		<idno type="DOI">10.1109/tbme.2022.3147066</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GVRsYu7">IEEE Trans Biomed Eng</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="2443" to="2455" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shandhi MMH, Fan J, Heller JA, Etemadi M, Klein L, Inan OT. Estimation of changes in intracardiac hemodynamics using wearable seismocardiography and machine learning in patients with heart failure: a feasibility study. IEEE Trans Biomed Eng. 2022;69:2443-2455. doi: 10.1109/tbme.2022.3147066</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_3zZQFEX">Performance analysis of gyroscope and accelerometer sensors for seismocardiographybased wearable pre-ejection period estimation</title>
		<author>
			<persName><forename type="first">Mmh</forename><surname>Shandhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Semiz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hersek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Goller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ayazi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">T</forename><surname>Inan</surname></persName>
		</author>
		<idno type="DOI">10.1109/jbhi.2019.2895775</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7U7GHuJ">IEEE J Biomed Health Inform</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="2365" to="2374" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Shandhi MMH, Semiz B, Hersek S, Goller N, Ayazi F, Inan OT. Performance analysis of gyroscope and accelerometer sensors for seismocardiography- based wearable pre-ejection period estimation. IEEE J Biomed Health Inform. 2019;23:2365-2374. doi: 10.1109/jbhi.2019.2895775</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_uc5v7tz">Personalized multimorbidity management for patients with type 2 diabetes using reinforcement learning of electronic health records</title>
		<author>
			<persName><forename type="first">H</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">O</forename><surname>Ryzhov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhong</surname></persName>
		</author>
		<idno type="DOI">10.1007/s40265-021-01484-3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MECEXyY">Drugs</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="515471" to="515515" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zheng H, Ryzhov IO, Xie W, Zhong J. Personalized multimorbid- ity management for patients with type 2 diabetes using reinforcement learning of electronic health records. Drugs. 2021;81:515471-515515. doi: 10.1007/s40265-021-01484-3</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_4Dxt3ku">Applying artificial intelligence to wearable sensor data to diagnose and predict cardiovascular disease: a review</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ramsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Leavey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Tja</forename><surname>Chico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Condell</surname></persName>
		</author>
		<idno type="DOI">10.3390/s22208002</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_NnWVZVE">Sensors</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page">8002</biblScope>
			<date type="published" when="2022">2022</date>
			<pubPlace>Basel)</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Huang JD, Wang J, Ramsey E, Leavey G, Chico TJA, Condell J. Apply- ing artificial intelligence to wearable sensor data to diagnose and predict cardiovascular disease: a review. Sensors (Basel). 2022;22:8002. doi: 10.3390/s22208002</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_u7SZKnV">Representation learning: a review and new perspectives</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Bengio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Courville</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Vincent</surname></persName>
		</author>
		<idno type="DOI">10.1109/tpami.2013.50</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZYUUw7D">IEEE Trans Pattern Anal Mach Intell</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1798" to="1828" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bengio Y, Courville A, Vincent P. Representation learning: a review and new perspectives. IEEE Trans Pattern Anal Mach Intell. 2013;35:1798-1828. doi: 10.1109/tpami.2013.50</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_Cmyeywn">Association of step volume and intensity with allcause mortality in older women</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Shiroma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Bassett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Buring</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2019.0899</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2fXpNn2">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">179</biblScope>
			<biblScope unit="page" from="1105" to="1112" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lee IM, Shiroma EJ, Kamada M, Bassett DR, Matthews CE, Buring JE. Association of step volume and intensity with all- cause mortality in older women. JAMA Intern Med. 2019;179:1105-1112. doi: 10.1001/jamainternmed.2019.0899</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_ZVfS9eR">Consumer-based wearable activity trackers increase physical activity participation: systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Brickwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Watson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>'brien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename></persName>
		</author>
		<idno type="DOI">10.2196/11819</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gCdc4xA">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">11819</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brickwood KJ, Watson G, O&apos;Brien J, Williams AD. Consumer-based wear- able activity trackers increase physical activity participation: systematic review and meta-analysis. JMIR Mhealth Uhealth. 2019;7:e11819. doi: 10.2196/11819</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_eNmRkrG">Interventions using wearable physical activity trackers among adults with cardiometabolic conditions: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hodkinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kontopantelis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Adeniji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Van Marwijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mcmillian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bower</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Panagioti</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamanetworkopen.2021.16382</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_k7M48Xm">JAMA Netw Open</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">2116382</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hodkinson A, Kontopantelis E, Adeniji C, van Marwijk H, McMillian B, Bower P, Panagioti M. Interventions using wearable physical activ- ity trackers among adults with cardiometabolic conditions: a systematic review and meta-analysis. JAMA Netw Open. 2021;4:e2116382. doi: 10.1001/jamanetworkopen.2021.16382</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_pF8KxJc">Effect of goal-setting approaches within a gamification intervention to increase physical activity among economically disadvantaged adults at elevated risk for major adverse cardiovascular events: the ENGAGE randomized clinical trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bachireddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Small</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Harrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">O</forename><surname>Harrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Oon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cal</forename><surname>Rareshide</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Snider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamacardio.2021.3176</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UJAFNc6">JAMA Cardiol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1387" to="1396" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Patel MS, Bachireddy C, Small DS, Harrison JD, Harrington TO, Oon AL, Rareshide CAL, Snider CK, Volpp KG. Effect of goal-setting approaches within a gamification intervention to increase physical activity among eco- nomically disadvantaged adults at elevated risk for major adverse car- diovascular events: the ENGAGE randomized clinical trial. JAMA Cardiol. 2021;6:1387-1396. doi: 10.1001/jamacardio.2021.3176</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_wuFdueN">Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study</title>
		<author>
			<persName><forename type="first">Jpj</forename><surname>Halcox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wareham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cardew</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gilmore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Barry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Gravenor</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.117.030583</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SPcFRYx">Circulation</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="1784" to="1794" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Halcox JPJ, Wareham K, Cardew A, Gilmore M, Barry JP, Phillips C, Gravenor MB. Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study. Circulation. 2017;136:1784-1794. doi: 10.1161/CIRCULATIONAHA.117.030583</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_3CK3NxU">Large-scale assessment of a smartwatch to identify atrial fibrillation</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Mahaffey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hedlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Rumsfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ferris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Balasubramanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rajmane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cheung</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa1901183</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_anGzjTa">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">381</biblScope>
			<biblScope unit="page" from="1909" to="1917" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Perez MV, Mahaffey KW, Hedlin H, Rumsfeld JS, Garcia A, Ferris T, Balasubramanian V, Russo AM, Rajmane A, Cheung L, et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med. 2019;381:1909-1917. doi: 10.1056/nejmoa1901183</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_mrqKQFC">Mobile photoplethysmographic technology to detect atrial fibrillation</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacc.2019.08.019</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dawegUQ">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="2365" to="2375" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Guo Y, Wang H, Zhang H, Liu T, Liang Z, Xia Y, Yan L, Xing Y, Shi H, Li S, et al. Mobile photoplethysmographic technology to detect atrial fibrillation. J Am Coll Cardiol. 2019;74:2365-2375. doi: 10.1016/j.jacc.2019.08.019</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_PG2Jk97">Early Prolonged Ambulatory Cardiac Monitoring in Stroke (EPACS): an open-label randomised controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kaura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sztriha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Aeron-Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Gall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Piechowski-Jozwiak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Teo</surname></persName>
		</author>
		<idno type="DOI">10.1186/s40001-019-0383-8</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_npJZbVw">Eur J Med Res</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page">25</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kaura A, Sztriha L, Chan FK, Aeron-Thomas J, Gall N, Piechowski- Jozwiak B, Teo JT. Early Prolonged Ambulatory Cardiac Monitoring in Stroke (EPACS): an open-label randomised controlled trial. Eur J Med Res. 2019;24:25. doi: 10.1186/s40001-019-0383-8</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_Vyk2gsU">Effect of continuous electrocardiogram monitoring on detection of undiagnosed atrial fibrillation after hospitalization for cardiac surgery: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">Act</forename><surname>Ha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Verma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Mazer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Quan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Yanagawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Latter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Yau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Jacques</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Singal</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamanetworkopen.2021.21867</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MZdnXhR">JAMA Netw Open</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">2121867</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ha ACT, Verma S, Mazer CD, Quan A, Yanagawa B, Latter DA, Yau TM, Jacques F, Brown CD, Singal RK, et al. Effect of continuous electrocardio- gram monitoring on detection of undiagnosed atrial fibrillation after hospi- talization for cardiac surgery: a randomized clinical trial. JAMA Netw Open. 2021;4:e2121867. doi: 10.1001/jamanetworkopen.2021.21867</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_7tbqDAD">Screening for atrial fibrillation in the older population: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Gladstone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wachter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schmalstieg-Bahr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">R</forename><surname>Quinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hummers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ivers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Marsden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Thornton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Djuric</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Suerbaum</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamacardio.2021.0038</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aUKcpaa">JAMA Cardiol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="558" to="567" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gladstone DJ, Wachter R, Schmalstieg-Bahr K, Quinn FR, Hummers E, Ivers N, Marsden T, Thornton A, Djuric A, Suerbaum J, et al. Screening for atrial fibrillation in the older population: a randomized clinical trial. JAMA Cardiol. 2021;6:558-567. doi: 10.1001/jamacardio.2021.0038</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_jSSyKR4">Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the Telemedical Interventional Monitoring in Heart Failure study</title>
		<author>
			<persName><forename type="first">F</forename><surname>Koehler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Winkler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schieber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Sechtem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stangl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Böhm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Boll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Baumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Honold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Koehler</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.111.018473</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7RRDD8h">Circulation</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="1873" to="1880" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M, Boll H, Baumann G, Honold M, Koehler K, et al. Impact of remote tele- medical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the Telemedical Interventional Moni- toring in Heart Failure study. Circulation. 2011;123:1873-1880. doi: 10.1161/circulationaha.111.018473</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_AHdcmuh">Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure: the Better Effectiveness After Transition --Heart Failure (BEAT-HF) randomized clinical trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Ong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Romano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Edgington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">U</forename><surname>Aronow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Auerbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Black</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Marco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Escarce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Evangelista</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Hanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2015.7712</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KbeWmeg">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page" from="310" to="318" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ong MK, Romano PS, Edgington S, Aronow HU, Auerbach AD, Black JT, De Marco T, Escarce JJ, Evangelista LS, Hanna B, et al. Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure: the Better Effectiveness After Transition --Heart Failure (BEAT- HF) randomized clinical trial. JAMA Intern Med. 2016;176:310-318. doi: 10.1001/jamainternmed.2015.7712</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_553HVmA">Efficacy of Telemedical Interventional Management in Patients With Heart Failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial</title>
		<author>
			<persName><forename type="first">F</forename><surname>Koehler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Koehler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Deckwart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Prescher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wegscheider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Kirwan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Winkler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vettorazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bruch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Oeff</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(18)31880-4</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MpNTMFC">Lancet</title>
		<imprint>
			<biblScope unit="volume">392</biblScope>
			<biblScope unit="page" from="1047" to="1057" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Kirwan BA, Winkler S, Vettorazzi E, Bruch L, Oeff M, et al. Efficacy of Telemedical Interven- tional Management in Patients With Heart Failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial. Lancet. 2018;392:1047-1057. doi: 10.1016/s0140-6736(18)31880-4</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_CPpYqpU">Continuous wearable monitoring analytics predict heart failure hospitalization: the LINK-HF multicenter study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Stehlik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schmalfuss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bozkurt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Nativi-Nicolau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Wohlfahrt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wegerich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schofield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Deswal</surname></persName>
		</author>
		<idno type="DOI">10.1161/CIRCHEARTFAILURE.119.006513</idno>
		<idno>DOI: 10.1161/CIRCRESAHA.122.322389</idno>
		<ptr target="http://ahajournals.org" />
	</analytic>
	<monogr>
		<title level="m" xml:id="_ws6ujdC">Wearable Devices in Cardiovascular Medicine</title>
		<imprint>
			<date type="published" when="2020-06-08">2020. June 8, 2025. 2023. March 3, 2023 669</date>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="652" to="670" />
		</imprint>
	</monogr>
	<note>Circ Heart Fail</note>
	<note type="raw_reference">Stehlik J, Schmalfuss C, Bozkurt B, Nativi-Nicolau J, Wohlfahrt P, Wegerich S, Rose K, Ray R, Schofield R, Deswal A, et al. Con- tinuous wearable monitoring analytics predict heart failure hospitalization: the LINK-HF multicenter study. Circ Heart Fail. 2020;13:e006513. doi: 10.1161/CIRCHEARTFAILURE.119.006513 Downloaded from http://ahajournals.org by on June 8, 2025 REVIEW Circulation Research. 2023;132:652-670. DOI: 10.1161/CIRCRESAHA.122.322389 March 3, 2023 669 Wearable Devices in Cardiovascular Medicine</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_BGXVNcv">Increasing the medium-term clinical benefits of hospital-based cardiac rehabilitation by physical activity telemonitoring in coronary artery disease patients</title>
		<author>
			<persName><forename type="first">I</forename><surname>Frederix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Van Driessche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bonne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Alders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dendale</surname></persName>
		</author>
		<idno type="DOI">10.1177/2047487313514018</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rkJyp7e">Eur J Prev Cardiol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="150" to="158" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Frederix I, Van Driessche N, Hansen D, Berger J, Bonne K, Alders T, Dendale P. Increasing the medium-term clinical benefits of hospital-based cardiac rehabilitation by physical activity telemonitoring in coronary artery disease patients. Eur J Prev Cardiol. 2015;22:150-158. doi: 10.1177/2047487313514018</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_BQjPuRP">Effects and costs of real-time cardiac telerehabilitation: randomised controlled non-inferiority trial</title>
		<author>
			<persName><forename type="first">R</forename><surname>Maddison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Rawstorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rah</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Benatar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Whittaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rolleston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moodie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Warren</surname></persName>
		</author>
		<idno type="DOI">10.1136/heartjnl-2018-313189</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_v6qWkCG">Heart</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="122" to="129" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Maddison R, Rawstorn JC, Stewart RAH, Benatar J, Whittaker R, Rolleston A, Jiang Y, Gao L, Moodie M, Warren I, et al. Effects and costs of real-time cardiac telerehabilitation: randomised controlled non-inferiority trial. Heart. 2019;105:122-129. doi: 10.1136/heartjnl-2018-313189</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_JrmNDzW">Effectiveness of cardiac telerehabilitation with relapse prevention: SmartCare-CAD randomized controlled trial</title>
		<author>
			<persName><forename type="first">Rwm</forename><surname>Brouwers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Kraal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Regis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Spee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hmc</forename><surname>Kemps</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacc.2021.03.328</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_g7BMSCk">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="2754" to="2756" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brouwers RWM, Kraal JJ, Regis M, Spee RF, Kemps HMC. Effective- ness of cardiac telerehabilitation with relapse prevention: SmartCare-CAD randomized controlled trial. J Am Coll Cardiol. 2021;77:2754-2756. doi: 10.1016/j.jacc.2021.03.328</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_bXHpbRp">Cost-effectiveness of cardiac telerehabilitation with relapse prevention for the treatment of patients with coronary artery disease in the Netherlands</title>
		<author>
			<persName><forename type="first">Rwm</forename><surname>Brouwers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ekj</forename><surname>Van Der Poort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hmc</forename><surname>Kemps</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Van Den Akker-Van Marle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Kraal</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamanetworkopen.2021.36652</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HBbqxqB">JAMA Netw Open</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">2136652</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brouwers RWM, van der Poort EKJ, Kemps HMC, van den Akker-van Marle ME, Kraal JJ. Cost-effectiveness of cardiac telerehabilitation with relapse prevention for the treatment of patients with coronary artery dis- ease in the Netherlands. JAMA Netw Open. 2021;4:e2136652. doi: 10.1001/jamanetworkopen.2021.36652</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_PzdWaj6">Home-based cardiac rehabilitation using information and communication technology for heart failure patients with frailty</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Nagatomi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ide</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Higuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nezu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fujino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tohyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nagata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Higo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hashimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Matsushima</surname></persName>
		</author>
		<idno type="DOI">10.1002/ehf2.13934</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xtZFwF6">ESC Heart Fail</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="2407" to="2418" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nagatomi Y, Ide T, Higuchi T, Nezu T, Fujino T, Tohyama T, Nagata T, Higo T, Hashimoto T, Matsushima S, et al. Home-based cardiac rehabilitation using information and communication technology for heart failure patients with frailty. ESC Heart Fail. 2022;9:2407-2418. doi: 10.1002/ehf2.13934</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_f8KTjTT">Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Gardner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Montgomery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Blevins</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.110.963066</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_93urg3C">Circulation</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="491" to="498" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gardner AW, Parker DE, Montgomery PS, Scott KJ, Blevins SM. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation. 2011;123:491-498. doi: 10.1161/circulationaha.110.963066</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_d3tZ3w8">Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Mcdermott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Guralnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Criqui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Spring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Domanchuk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ferrucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lloyd</forename><forename type="middle">-</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kibbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.1001/jama.2013.7231</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4paaf3y">JAMA</title>
		<imprint>
			<biblScope unit="volume">310</biblScope>
			<biblScope unit="page" from="57" to="65" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McDermott MM, Liu K, Guralnik JM, Criqui MH, Spring B, Tian L, Domanchuk K, Ferrucci L, Lloyd-Jones D, Kibbe M, et al. Home-based walk- ing exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA. 2013;310:57-65. doi: 10.1001/jama.2013.7231</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_cA37Q6z">Effect of a home-based exercise intervention of wearable technology and telephone coaching on walking performance in peripheral artery disease: the HONOR randomized clinical trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Mcdermott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Spring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Treat-Jacobson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Conte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Creager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Criqui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ferrucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Gornik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Guralnik</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2018.3275</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7w2WuM2">JAMA</title>
		<imprint>
			<biblScope unit="volume">319</biblScope>
			<biblScope unit="page" from="1665" to="1676" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McDermott MM, Spring B, Berger JS, Treat-Jacobson D, Conte MS, Creager MA, Criqui MH, Ferrucci L, Gornik HL, Guralnik JM, et al. Effect of a home-based exercise intervention of wearable technology and tele- phone coaching on walking performance in peripheral artery disease: the HONOR randomized clinical trial. JAMA. 2018;319:1665-1676. doi: 10.1001/jama.2018.3275</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_FDR9vkz">Effect of low-intensity vs high-intensity home-based walking exercise on walk distance in patients with peripheral artery disease: the LITE randomized clinical trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Mcdermott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Spring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Treat-Jacobson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ferrucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lloyd</forename><forename type="middle">-</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Polonsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kibbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Bazzano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
		<idno type="DOI">10.1001/jama.2021.2536</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TP4Xbhd">JAMA</title>
		<imprint>
			<biblScope unit="volume">325</biblScope>
			<biblScope unit="page" from="1266" to="1276" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McDermott MM, Spring B, Tian L, Treat-Jacobson D, Ferrucci L, Lloyd-Jones D, Zhao L, Polonsky T, Kibbe MR, Bazzano L, et al. Effect of low-intensity vs high-intensity home-based walking exercise on walk dis- tance in patients with peripheral artery disease: the LITE randomized clinical trial. JAMA. 2021;325:1266-1276. doi: 10.1001/jama.2021.2536</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_3HH7vm2">Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Riddlesworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ruedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ahmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Haller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kruger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Mcgill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Polonsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Aronoff</surname></persName>
		</author>
		<idno type="DOI">10.7326/m16-2855</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hhGEvMA">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="page" from="365" to="374" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Beck RW, Riddlesworth TD, Ruedy K, Ahmann A, Haller S, Kruger D, McGill JB, Polonsky W, Price D, Aronoff S, et al. Continuous glucose moni- toring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017;167:365- 374. doi: 10.7326/m16-2855</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_hqADWts">Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">T</forename><surname>Martens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Ruedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Calhoun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pop-Busui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Philis</forename><forename type="middle">-</forename><surname>Tsimikas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Umpierrez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
		<idno type="DOI">10.1001/jama.2021.7444</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8bERqDd">JAMA</title>
		<imprint>
			<biblScope unit="volume">325</biblScope>
			<biblScope unit="page" from="2262" to="2272" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Martens T, Beck RW, Bailey R, Ruedy KJ, Calhoun P, Peters AL, Pop-Busui R, Philis-Tsimikas A, Bao S, Umpierrez G, et al. Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial. JAMA. 2021;325:2262-2272. doi: 10.1001/jama.2021.7444</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_yjN2kzt">Intermittently scanned continuous glucose monitoring for type 1 diabetes</title>
		<author>
			<persName><forename type="first">L</forename><surname>Leelarathna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Neupane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rayman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lumley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Cranston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Narendran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Barnard-Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Sutton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Elliott</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa2205650</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4K3KyYH">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">387</biblScope>
			<biblScope unit="page" from="1477" to="1487" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Leelarathna L, Evans ML, Neupane S, Rayman G, Lumley S, Cranston I, Narendran P, Barnard-Kelly K, Sutton CJ, Elliott RA, et al. Intermittently scanned continuous glucose monitoring for type 1 diabetes. N Engl J Med. 2022;387:1477-1487. doi: 10.1056/nejmoa2205650</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_3C6tzRP">Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Shiroma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lobelo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Puska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Blair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Katzmarzyk</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(12)61031-9</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gejShTf">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="page" from="219" to="229" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Effect of physical inactivity on major non-communicable diseases worldwide: an anal- ysis of burden of disease and life expectancy. Lancet. 2012;380:219-229. doi: 10.1016/s0140-6736(12)61031-9</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_7NuwPEa">Association of step counts over time with the risk of chronic disease in the All of Us research program</title>
		<author>
			<persName><forename type="first">H</forename><surname>Master</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Annis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Beckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ratsimbazafy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Marginean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Carroll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Natarajan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Harrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Roden</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41591-022-02012-w</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FNrX2KK">Nat Med</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="2301" to="2308" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Master H, Annis J, Huang S, Beckman JA, Ratsimbazafy F, Marginean K, Carroll R, Natarajan K, Harrell FE, Roden DM, et al. Asso- ciation of step counts over time with the risk of chronic disease in the All of Us research program. Nat Med. 2022;28:2301-2308. doi: 10.1038/s41591-022-02012-w</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_BRNYpvr">Effectiveness of an activity tracker-and internet-based adaptive walking program for adults: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><surname>Poirier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Jerome</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lazo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Yeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Cobb</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.5295</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_U7MNeGG">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page">34</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Poirier J, Bennett WL, Jerome GJ, Shah NG, Lazo M, Yeh HC, Clark JM, Cobb NK. Effectiveness of an activity tracker-and internet-based adaptive walking program for adults: a randomized controlled trial. J Med Internet Res. 2016;18:e34. doi: 10.2196/jmir.5295</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main" xml:id="_dk87SzB">mActive: a randomized clinical trial of an automated mHealth intervention for physical activity promotion</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">I</forename><surname>Feldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Blumenthal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Post</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Mckibben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Michos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Ndumele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">V</forename><surname>Ratchford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Coresh</surname></persName>
		</author>
		<idno type="DOI">10.1161/JAHA.115.002239</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZkNC2Ws">J Am Heart Assoc</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">2239</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Martin SS, Feldman DI, Blumenthal RS, Jones SR, Post WS, McKibben RA, Michos ED, Ndumele CE, Ratchford EV, Coresh J, et al. mActive: a randomized clinical trial of an automated mHealth intervention for physical activity promotion. J Am Heart Assoc. 2015;4:e002239. doi: 10.1161/JAHA.115.002239</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_xr5QW39">A mobile health intervention to increase physical activity in pulmonary arterial hypertension</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Hemnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Silverman-Lloyd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mackinnon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Annis</forename><forename type="middle">J</forename><surname>Whitmore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Mallugari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Oggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Hekmat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Shan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.chest.2021.04.012</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_WmJH7Fq">Chest</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="1042" to="1052" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hemnes AR, Silverman-Lloyd LG, Huang S, MacKinnon G, Annis J, Whitmore CS, Mallugari R, Oggs RN, Hekmat R, Shan R, et al. A mobile health intervention to increase physical activity in pulmonary arterial hyper- tension. Chest. 2021;160:1042-1052. doi: 10.1016/j.chest.2021.04.012</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main" xml:id="_7Z5rT3A">Effect of a game-based intervention designed to enhance social incentives to increase physical activity among families: the BE FIT randomized clinical trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Benjamin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Small</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Massaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Hilbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Valentino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Taylor</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamainternmed.2017.3458</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7bEnA88">JAMA Intern Med</title>
		<imprint>
			<biblScope unit="volume">177</biblScope>
			<biblScope unit="page" from="1586" to="1593" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Patel MS, Benjamin EJ, Volpp KG, Fox CS, Small DS, Massaro JM, Lee JJ, Hilbert V, Valentino M, Taylor DH, et al. Effect of a game-based inter- vention designed to enhance social incentives to increase physical activ- ity among families: the BE FIT randomized clinical trial. JAMA Intern Med. 2017;177:1586-1593. doi: 10.1001/jamainternmed.2017.3458</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main" xml:id="_y4eZtZR">Effect of behaviorally designed gamification with social incentives on lifestyle modification among adults with uncontrolled diabetes: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Small</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Harrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Hilbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Fortunato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Oon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cal</forename><surname>Rareshide</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Volpp</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamanetworkopen.2021.10255</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Z33PHe5">JAMA Netw Open</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">2110255</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Patel MS, Small DS, Harrison JD, Hilbert V, Fortunato MP, Oon AL, Rareshide CAL, Volpp KG. Effect of behaviorally designed gamification with social incentives on lifestyle modification among adults with uncontrolled diabetes: a randomized clinical trial. JAMA Netw Open. 2021;4:e2110255. doi: 10.1001/jamanetworkopen.2021.10255</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main" xml:id="_vM2sKAM">Effect of gamification with and without financial incentives to increase physical activity among veterans classified as having obesity or overweight: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Agarwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Waddell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Small</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">O</forename><surname>Harrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Djaraher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Oon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Patel</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamanetworkopen.2021.16256</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uGaCMGJ">JAMA Netw Open</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">2116256</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Agarwal AK, Waddell KJ, Small DS, Evans C, Harrington TO, Djaraher R, Oon AL, Patel MS. Effect of gamification with and without financial incentives to increase physical activity among veterans classified as having obesity or overweight: a randomized clinical trial. JAMA Netw Open. 2021;4:e2116256. doi: 10.1001/jamanetworkopen.2021.16256</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main" xml:id="_nTUuvxE">Evaluating the effectiveness of gamification on physical activity: systematic review and meta-analysis of randomized controlled trials</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mazeas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Duclos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chalabaev</surname></persName>
		</author>
		<idno type="DOI">10.2196/26779</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mwX3yGr">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page">26779</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mazeas A, Duclos M, Pereira B, Chalabaev A. Evaluating the effectiveness of gamification on physical activity: systematic review and meta-analysis of randomized controlled trials. J Med Internet Res. 2022;24:e26779. doi: 10.2196/26779</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main" xml:id="_G8msVb4">Virtual Application-Supported Environment to Increase Exercise (VALENTINE) during cardiac rehabilitation study: rationale and design</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Jeganathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Golbus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Luff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Dempsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Boyden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rubenfire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mukherjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Klasnja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kheterpal</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ahj.2022.02.012</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_6zY8D7X">Am Heart J</title>
		<imprint>
			<biblScope unit="volume">248</biblScope>
			<biblScope unit="page" from="53" to="62" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Jeganathan VS, Golbus JR, Gupta K, Luff E, Dempsey W, Boyden T, Rubenfire M, Mukherjee B, Klasnja P, Kheterpal S, et al. Virtual Application- Supported Environment to Increase Exercise (VALENTINE) during cardiac rehabilitation study: rationale and design. Am Heart J. 2022;248:53-62. doi: 10.1016/j.ahj.2022.02.012</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main" xml:id="_dFVwh8N">A systematic review of just-in-time adaptive interventions (JITAIs) to promote physical activity</title>
		<author>
			<persName><forename type="first">W</forename><surname>Hardeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Houghton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Naughton</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12966-019-0792-7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_rKuqMsE">Int J Behav Nutr Phys Act</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">31</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hardeman W, Houghton J, Lane K, Jones A, Naughton F. A systematic review of just-in-time adaptive interventions (JITAIs) to promote physical activity. Int J Behav Nutr Phys Act. 2019;16:31. doi: 10.1186/s12966-019-0792-7</note>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main" xml:id="_bnR4dd6">Socioeconomic status and cardiovascular outcomes: challenges and interventions</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Schultz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Kelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Lisko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Varghese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sandesara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Quyyumi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gulati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Harold</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.117.029652</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qBmk8cz">Circulation</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="2166" to="2178" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Schultz WM, Kelli HM, Lisko JC, Varghese T, Shen J, Sandesara P, Quyyumi AA, Taylor HA, Gulati M, Harold JG, et al. Socioeconomic status and cardiovascular outcomes: challenges and interventions. Circulation. 2018;137:2166-2178. doi: 10.1161/circulationaha.117.029652</note>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main" xml:id="_jNaNcap">ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS</title>
		<author>
			<persName><forename type="first">P</forename><surname>Kirchhof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Benussi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kotecha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ahlsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Atar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Casadei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Castella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Diener</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Heidbuchel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hendriks</surname></persName>
		</author>
		<idno type="DOI">10.1093/europace/euw295</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_YyqhEK3">Europace</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1609" to="1678" />
			<date type="published" when="2016">2016. 2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace. 2016;18:1609-1678. doi: 10.1093/europace/euw295</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main" xml:id="_CWKtzcr">Diagnostic utility of a novel leadless arrhythmia monitoring device</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Turakhia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Hoang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zimetbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">F</forename><surname>Froelicher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">N</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Heidenreich</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amjcard.2013.04.017</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_24x3CkE">Am J Cardiol</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="520" to="524" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Turakhia MP, Hoang DD, Zimetbaum P, Miller JD, Froelicher VF, Kumar UN, Xu X, Yang F, Heidenreich PA. Diagnostic utility of a novel lead- less arrhythmia monitoring device. Am J Cardiol. 2013;112:520-524. doi: 10.1016/j.amjcard.2013.04.017</note>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main" xml:id="_JUtnVTm">Three year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening-mHealth Screening to Prevent Strokes (mSToPS)</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Steinhubl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Waalen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sanyal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Ariniello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Ebner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Baca-Motes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Zambon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sarich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Topol</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0258276</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_az3Zt9H">PLoS One</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">258276</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Steinhubl SR, Waalen J, Sanyal A, Edwards AM, Ariniello LM, Ebner GS, Baca-Motes K, Zambon RA, Sarich T, Topol EJ. Three year clinical out- comes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening-mHealth Screening to Prevent Strokes (mSToPS). PLoS One. 2021;16:e0258276. doi: 10.1371/journal.pone.0258276</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main" xml:id="_Uq2T35Y">Accuracy of apple watch for detection of atrial fibrillation</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Seshadri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bittel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Browsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Houghtaling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Drummond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Desai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Gillinov</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.119.044126</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_d2DJZBr">Circulation</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="702" to="703" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Seshadri DR, Bittel B, Browsky D, Houghtaling P, Drummond CK, Desai MY, Gillinov AM. Accuracy of apple watch for detection of atrial fibrillation. Circulation. 2020;141:702-703. doi: 10.1161/circulationaha.119.044126</note>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main" xml:id="_jChAqqs">Comparison of 2 smart watch algorithms for detection of atrial fibrillation and the benefit of clinician interpretation: SMART WARS study</title>
		<author>
			<persName><forename type="first">C</forename><surname>Ford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">X</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Low</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rajakariar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Koshy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Sajeev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Pathik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Teh</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacep.2022.02.013</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fgKsXvR">JACC Clin Electrophysiol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="782" to="791" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ford C, Xie CX, Low A, Rajakariar K, Koshy AN, Sajeev JK, Roberts L, Pathik B, Teh AW. Comparison of 2 smart watch algorithms for detection of atrial fibril- lation and the benefit of clinician interpretation: SMART WARS study. JACC Clin Electrophysiol. 2022;8:782-791. doi: 10.1016/j.jacep.2022.02.013</note>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main" xml:id="_jfzuRFV">Effect of a telemonitoring-facilitated collaboration between general practitioner and heart failure clinic on mortality and rehospitalization rates in severe heart failure: the TEMA-HF 1 (Telemonitoring in the Management of Heart Failure) study</title>
		<author>
			<persName><forename type="first">P</forename><surname>Dendale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Keulenaer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Troisfontaines</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Weytjens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mullens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Elegeert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ector</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Houbrechts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Willekens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
		<idno type="DOI">10.1093/eurjhf/hfr144</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MyTY6Xb">Eur J Heart Fail</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="333" to="340" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dendale P, De Keulenaer G, Troisfontaines P, Weytjens C, Mullens W, Elegeert I, Ector B, Houbrechts M, Willekens K, Hansen D. Effect of a tele- monitoring-facilitated collaboration between general practitioner and heart failure clinic on mortality and rehospitalization rates in severe heart failure: the TEMA-HF 1 (Telemonitoring in the Management of Heart Failure) study. Eur J Heart Fail. 2012;14:333-340. doi: 10.1093/eurjhf/hfr144</note>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main" xml:id="_ywpJzjS">Design and performance of a multisensor heart failure monitoring algorithm: results from the Multisensor Monitoring in Congestive Heart Failure (MUSIC) study</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Anand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Greenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Chakravarthy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Libbus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Katra</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cardfail.2012.01.009</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UDb9XEx">J Card Fail</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="289" to="295" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Anand IS, Tang WH, Greenberg BH, Chakravarthy N, Libbus I, Katra RP. Design and performance of a multisensor heart failure monitoring algorithm: results from the Multisensor Monitoring in Congestive Heart Failure (MUSIC) study. J Card Fail. 2012;18:289-295. doi: 10.1016/j.cardfail.2012.01.009</note>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main" xml:id="_QBgb8q4">Evaluation of remote dielectric sensing (ReDS) technologyguided therapy for decreasing heart failure re-hospitalizations</title>
		<author>
			<persName><forename type="first">O</forename><surname>Amir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ben-Gal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Weinstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schliamser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Burkhoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Abbo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Abraham</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijcard.2017.02.120</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MsTaDpC">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">240</biblScope>
			<biblScope unit="page" from="279" to="284" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Amir O, Ben-Gal T, Weinstein JM, Schliamser J, Burkhoff D, Abbo A, Abraham WT. Evaluation of remote dielectric sensing (ReDS) technology- guided therapy for decreasing heart failure re-hospitalizations. Int J Cardiol. 2017;240:279-284. doi: 10.1016/j.ijcard.2017.02.120</note>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main" xml:id="_xxt9AnG">Early use of remote dielectric sensing after hospitalization to reduce heart failure readmissions</title>
		<author>
			<persName><forename type="first">A</forename><surname>Lala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Barghash</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Giustino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Alvarez-Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Konje</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Parikh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ullman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Keith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Donehey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Mitter</surname></persName>
		</author>
		<idno type="DOI">10.1002/ehf2.13026</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vnAN8Zg">ESC Heart Fail</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1047" to="1054" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lala A, Barghash MH, Giustino G, Alvarez-Garcia J, Konje S, Parikh A, Ullman J, Keith B, Donehey J, Mitter SS, et al. Early use of remote dielec- tric sensing after hospitalization to reduce heart failure readmissions. ESC Heart Fail. 2021;8:1047-1054. doi: 10.1002/ehf2.13026</note>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main" xml:id="_AhGnaNP">Isosorbide mononitrate in heart failure with preserved ejection fraction</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Redfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Anstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Levine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Koepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Borlaug</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Lewinter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Joseph</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Semigran</surname></persName>
		</author>
		<idno type="DOI">10.1056/nejmoa1510774</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xJmDcPT">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">373</biblScope>
			<biblScope unit="page" from="2314" to="2324" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Redfield MM, Anstrom KJ, Levine JA, Koepp GA, Borlaug BA, Chen HH, LeWinter MM, Joseph SM, Shah SJ, Semigran MJ, et al. Isosorbide mono- nitrate in heart failure with preserved ejection fraction. N Engl J Med. 2015;373:2314-2324. doi: 10.1056/nejmoa1510774</note>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main" xml:id="_bPTp4e5">The AWAKE-HF study: sacubitril/valsartan impact on daily physical activity and sleep in heart failure</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Khandwalla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Grant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Birkeland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Heywood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fombu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Owens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Steinhubl</surname></persName>
		</author>
		<idno type="DOI">10.1007/s40256-020-00440-y</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mM49cGa">Am J Cardiovasc Drugs</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="241" to="254" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Khandwalla RM, Grant D, Birkeland K, Heywood JT, Fombu E, Owens RL, Steinhubl SR. The AWAKE-HF study: sacubitril/valsartan impact on daily physical activity and sleep in heart failure. Am J Cardiovasc Drugs. 2021;21:241-254. doi: 10.1007/s40256-020-00440-y</note>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main" xml:id="_5ZFdpDy">Sleep outcomes from AWAKE-HF: a randomized clinical trial of sacubitril/valsartan vs enalapril in patients with heart failure and reduced ejection fraction</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Owens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Birkeland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Heywood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Steinhubl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Grant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fombu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Khandwalla</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cardfail.2021.07.021</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_8jV3vC3">J Card Fail</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="1466" to="1471" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Owens RL, Birkeland K, Heywood JT, Steinhubl SR, Dorn J, Grant D, Fombu E, Khandwalla R. Sleep outcomes from AWAKE-HF: a randomized clini- cal trial of sacubitril/valsartan vs enalapril in patients with heart failure and reduced ejection fraction. J Card Fail. 2021;27:1466-1471. doi: 10.1016/j.cardfail.2021.07.021</note>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main" xml:id="_HgASZAW">Cognitive behavioral therapy for insomnia has sustained effects on insomnia, fatigue, and function among people with chronic heart failure and insomnia: the Heart-Sleep study</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Redeker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Yaggi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jacoby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Hollenbeak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Breazeale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Conley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hwang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Iennaco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Linsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Nwanaji-Enwerem</surname></persName>
		</author>
		<idno type="DOI">10.1093/sleep/zsab252</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UvFxXEm">Sleep</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page">252</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Redeker NS, Yaggi HK, Jacoby D, Hollenbeak CS, Breazeale S, Conley S, Hwang Y, Iennaco J, Linsky S, Nwanaji-Enwerem U, et al. Cognitive behav- ioral therapy for insomnia has sustained effects on insomnia, fatigue, and function among people with chronic heart failure and insomnia: the Heart- Sleep study. Sleep. 2022;45:zsab252. doi: 10.1093/sleep/zsab252</note>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main" xml:id="_KhJW7He">Home-based cardiac rehabilitation: a scientific statement from the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Beatty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Beckie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Brewer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Forman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Franklin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Keteyian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Kitzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Regensteiner</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacc.2019.03.008</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ncxhJRr">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="133" to="153" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Thomas RJ, Beatty AL, Beckie TM, Brewer LC, Brown TM, Forman DE, Franklin BA, Keteyian SJ, Kitzman DW, Regensteiner JG, et al. Home-based cardiac rehabilitation: a scientific statement from the American Associa- tion of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology. J Am Coll Cardiol. 2019;74:133-153. doi: 10.1016/j.jacc.2019.03.008</note>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main" xml:id="_k4mCWnr">AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines</title>
		<author>
			<persName><forename type="first">Gerhard-Herman Md</forename><surname>Gornik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Barshes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Corriere</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Drachman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Fleisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Fowkes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">G</forename><surname>Hamburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Kinlay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
		<idno type="DOI">10.1161/CIR.0000000000000470</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dkJpkaU">Circulation</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="686" to="e725" />
			<date type="published" when="2016">2016. 2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, et al. 2016 AHA/ACC guideline on the management of patients with lower extrem- ity peripheral artery disease: executive summary: a report of the Ameri- can College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e686-e725. doi: 10.1161/CIR.0000000000000470</note>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main" xml:id="_ce8YuJx">Effect of smartphone-enabled health monitoring devices vs regular follow-up on blood pressure control among patients after myocardial infarction: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Treskes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lam</forename><surname>Van Winden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Van Keulen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">T</forename><surname>Van Der Velde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Beeres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Atsma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Schalij</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamanetworkopen.2020.2165</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ngdwSwK">JAMA Netw Open</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">202165</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Treskes RW, van Winden LAM, van Keulen N, van der Velde ET, Beeres S, Atsma DE, Schalij MJ. Effect of smartphone-enabled health monitoring devices vs regular follow-up on blood pressure control among patients after myocardial infarction: a randomized clinical trial. JAMA Netw Open. 2020;3:e202165. doi: 10.1001/jamanetworkopen.2020.2165</note>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main" xml:id="_Uwm9BQt">Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Xia</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc20-1862</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Tr2vtKx">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="549" to="555" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lu J, Wang C, Shen Y, Chen L, Zhang L, Cai J, Lu W, Zhu W, Hu G, Xia T, et al. Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study. Diabetes Care. 2021;44:549-555. doi: 10.2337/dc20-1862</note>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main" xml:id="_AerNDKJ">Association between glycemic control assessed by continuous glucose monitoring and stroke in patients with atrial fibrillation and diabetes mellitus</title>
		<author>
			<persName><forename type="first">J</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yu</surname></persName>
		</author>
		<idno type="DOI">10.21037/apm-21-2198</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dj4AFUX">Ann Palliat Med</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="9157" to="9164" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Guo J, Wang J, Zhao Z, Yu L. Association between glycemic control assessed by continuous glucose monitoring and stroke in patients with atrial fibrillation and diabetes mellitus. Ann Palliat Med. 2021;10:9157-9164. doi: 10.21037/apm-21-2198</note>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main" xml:id="_4BdGeFA">Back to the future: achieving health equity through health informatics and digital health</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Brewer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Fortuna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Hayes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Patten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Cooper</surname></persName>
		</author>
		<idno type="DOI">10.2196/14512</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PM59DKy">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">14512</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brewer LC, Fortuna KL, Jones C, Walker R, Hayes SN, Patten CA, Cooper LA. Back to the future: achieving health equity through health informatics and digital health. JMIR Mhealth Uhealth. 2020;8:e14512. doi: 10.2196/14512</note>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main" xml:id="_NGzsBVY">Patient characteristics associated with telemedicine access for primary and specialty ambulatory care during the COVID-19 pandemic</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Eberly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Kallan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Julien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Haynes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sam</forename><surname>Khatana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Nathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Snider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Chokshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Eneanya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">U</forename><surname>Takvorian</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamanetworkopen.2020.31640</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kpbpgR9">JAMA Netw Open</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">2031640</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Eberly LA, Kallan MJ, Julien HM, Haynes N, Khatana SAM, Nathan AS, Snider C, Chokshi NP, Eneanya ND, Takvorian SU, et al. Patient charac- teristics associated with telemedicine access for primary and specialty ambulatory care during the COVID-19 pandemic. JAMA Netw Open. 2020;3:e2031640. doi: 10.1001/jamanetworkopen.2020.31640</note>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main" xml:id="_MUGB96q">Internet access as a social determinant of health</title>
		<author>
			<persName><forename type="first">R</forename><surname>Rubin</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.2021.11733</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hHn6KgF">JAMA</title>
		<imprint>
			<biblScope unit="volume">326</biblScope>
			<biblScope unit="page">298</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rubin R. Internet access as a social determinant of health. JAMA. 2021;326:298. doi: 10.1001/jama.2021.11733</note>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main" xml:id="_64AHdDs">Designing effective eHealth interventions for underserved groups: five lessons from a decade of eHealth intervention design and deployment</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">W</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Mccloud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Viswanath</surname></persName>
		</author>
		<idno type="DOI">10.2196/25419</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PwMDjHT">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page">25419</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lee EW, McCloud RF, Viswanath K. Designing effective eHealth interven- tions for underserved groups: five lessons from a decade of eHealth inter- vention design and deployment. J Med Internet Res. 2022;24:e25419. doi: 10.2196/25419</note>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main" xml:id="_qYwjMbP">Big data in context: addressing the twin perils of data absenteeism and chauvinism in the context of health disparities research</title>
		<author>
			<persName><forename type="first">Ewj</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Viswanath</surname></persName>
		</author>
		<idno type="DOI">10.2196/16377</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qp8YxaR">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page">16377</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lee EWJ, Viswanath K. Big data in context: addressing the twin perils of data absenteeism and chauvinism in the context of health disparities research. J Med Internet Res. 2020;22:e16377. doi: 10.2196/16377</note>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main" xml:id="_4ve9seu">Too old for technology? Use of wearable healthcare devices by older adults and their willingness to share health data with providers</title>
		<author>
			<persName><forename type="first">R</forename><surname>Chandrasekaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Katthula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Moustakas</surname></persName>
		</author>
		<idno type="DOI">10.1177/14604582211058073</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_t3KUxcQ">Health Informatics J</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page">14604582211058073</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chandrasekaran R, Katthula V, Moustakas E. Too old for technol- ogy? Use of wearable healthcare devices by older adults and their willingness to share health data with providers. Health Informatics J. 2021;27:14604582211058073. doi: 10.1177/14604582211058073</note>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main" xml:id="_27TveTK">Understanding factors influencing the adoption of mHealth by the elderly: an extension of the UTAUT model</title>
		<author>
			<persName><forename type="first">R</forename><surname>Hoque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sorwar</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijmedinf.2017.02.002</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vGG2EHU">Int J Med Inform</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="75" to="84" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hoque R, Sorwar G. Understanding factors influencing the adoption of mHealth by the elderly: an extension of the UTAUT model. Int J Med Inform. 2017;101:75-84. doi: 10.1016/j.ijmedinf.2017.02.002</note>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main" xml:id="_tXzspcV">The antecedents and results of seniors&apos; use of activity tracking wearable devices</title>
		<author>
			<persName><forename type="first">M</forename><surname>Abouzahra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ghasemaghaei</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.hlpt.2019.11.002</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FsyXJhc">Health Policy and Technology</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="213" to="217" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Abouzahra M, Ghasemaghaei M. The antecedents and results of seniors&apos; use of activity tracking wearable devices. Health Policy and Technology. 2020;9:213-217. doi: 10.1016/j.hlpt.2019.11.002</note>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main" xml:id="_fzQGeSa">Modernizing and designing evaluation frameworks for connected sensor technologies in medicine</title>
		<author>
			<persName><forename type="first">A</forename><surname>Coravos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Doerr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Goldsack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Manta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Shervey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Woods</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wood</forename><forename type="middle">Wa</forename></persName>
		</author>
		<idno type="DOI">10.1038/s41746-020-0237-3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_M9PAC98">NPJ Digit Med</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">37</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Coravos A, Doerr M, Goldsack J, Manta C, Shervey M, Woods B, Wood WA. Modernizing and designing evaluation frameworks for connected sensor technologies in medicine. NPJ Digit Med. 2020;3:37. doi: 10.1038/s41746-020-0237-3</note>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main" xml:id="_hrQE9d2">Big data in cardiology: state-of-art and future prospects</title>
		<author>
			<persName><forename type="first">H</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Younis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Kong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Puce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Jabbour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">L</forename><surname>Bragazzi</surname></persName>
		</author>
		<idno type="DOI">10.3389/fcvm.2022.844296</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9ZBMgZ5">Front Cardiovasc Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">844296</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dai H, Younis A, Kong JD, Puce L, Jabbour G, Yuan H, Bragazzi NL. Big data in cardiology: state-of-art and future prospects. Front Cardiovasc Med. 2022;9:844296. doi: 10.3389/fcvm.2022.844296</note>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main" xml:id="_3aHG8eg">Cardiovascular outcomes trials in type 2 diabetes: where do we go from here? Reflections from a diabetes care editors&apos; expert forum</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Cefalu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kaul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Gerstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Holman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zinman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Skyler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Buse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Inzucchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Leiter</surname></persName>
		</author>
		<idno type="DOI">10.2337/dci17-0057</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_gkas5CE">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="14" to="31" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cefalu WT, Kaul S, Gerstein HC, Holman RR, Zinman B, Skyler JS, Green JB, Buse JB, Inzucchi SE, Leiter LA, et al. Cardiovascular outcomes trials in type 2 diabetes: where do we go from here? Reflections from a diabetes care editors&apos; expert forum. Diabetes Care. 2018;41:14-31. doi: 10.2337/dci17-0057</note>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main" xml:id="_Cgqdwmu">Wearable health technology and electronic health record integration: scoping review and future directions</title>
		<author>
			<persName><forename type="first">C</forename><surname>Dinh-Le</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Chuang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chokshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mann</surname></persName>
		</author>
		<idno type="DOI">10.2196/12861</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_K8rKudw">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">12861</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dinh-Le C, Chuang R, Chokshi S, Mann D. Wearable health technology and electronic health record integration: scoping review and future directions. JMIR Mhealth Uhealth. 2019;7:e12861. doi: 10.2196/12861</note>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main" xml:id="_WJmvSGu">Wearable devices and healthcare: data sharing and privacy</title>
		<author>
			<persName><forename type="first">S</forename><surname>Banerjee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hemphill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Longstreet</surname></persName>
		</author>
		<idno type="DOI">10.1080/01972243.2017.1391912</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tggtqkr">The Information Society</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="49" to="57" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Banerjee S, Hemphill T, Longstreet P. Wearable devices and healthcare: data sharing and privacy. The Information Society. 2018;34:49-57.</note>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main" xml:id="_MvmhFgw">The emerging clinical role of wearables: factors for successful implementation in healthcare</title>
		<author>
			<persName><forename type="first">M</forename><surname>Smuck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Odonkor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Wilt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Swiernik</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41746-021-00418-3</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VeF6wVV">NPJ Digit Med</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">45</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Smuck M, Odonkor CA, Wilt JK, Schmidt N, Swiernik MA. The emerging clinical role of wearables: factors for successful implementation in health- care. NPJ Digit Med. 2021;4:45. doi: 10.1038/s41746-021-00418-3</note>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main" xml:id="_eWwjqDW">The FAIR guiding principles for scientific data management and stewardship</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Wilkinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dumontier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Aalbersberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Appleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Axton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Baak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Blomberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Boiten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Silva</forename><surname>Da</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Santos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Bourne</surname></persName>
		</author>
		<idno type="DOI">10.1038/sdata.2016.18</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2RfenzE">Sci Data</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">160018</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wilkinson MD, Dumontier M, Aalbersberg IJ, Appleton G, Axton M, Baak A, Blomberg N, Boiten JW, da Silva Santos LB, Bourne PE, et al. The FAIR guiding principles for scientific data management and stew- ardship. Sci Data. 2016;3:160018. doi: 10.1038/sdata.2016.18</note>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main" xml:id="_nSxHBuB">A systematic review of wearable patient monitoring systems -current challenges and opportunities for clinical adoption</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Baig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Gholamhosseini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Moqeem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mirza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lindén</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10916-017-0760-1100</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DsGeKhH">J Med Syst</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page">115</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Baig MM, GholamHosseini H, Moqeem AA, Mirza F, Lindén M. A system- atic review of wearable patient monitoring systems -current challenges and opportunities for clinical adoption. J Med Syst. 2017;41:115. doi: 10.1007/s10916-017-0760-1 100.</note>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main" xml:id="_QSmqhNH">iCoDE Report: CGM-EHR Integration Standards and Recommendations</title>
		<author>
			<persName><forename type="first">J</forename><surname>Espinoza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Klonoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vidmar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Corathers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Seigel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yeung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Babaei</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_PMDgysZ">Diabetes Technology Society</title>
		<imprint>
			<biblScope unit="page">101</biblScope>
			<date type="published" when="2022">2022. 2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Espinoza J, Klonoff D, Vidmar A, Tut M, Corathers S, Seigel R, Yeung A, Xu N, Shah P, Babaei M, et al. 2022 iCoDE Report: CGM-EHR Integration Standards and Recommendations. Diabetes Technology Society. 2022. 101.</note>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main" xml:id="_jvc42Cr">Leveraging remote physiologic monitoring in the COVID-19 pandemic to improve care after cardiovascular hospitalizations</title>
		<author>
			<persName><forename type="first">P</forename><surname>Dey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jarrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Geirsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Krumholz</surname></persName>
		</author>
		<idno type="DOI">10.1161/CIRCOUTCOMES.120.007618102</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KUUU2vt">Circ Cardiovasc Qual Outcomes</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">7618</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dey P, Jarrin R, Mori M, Geirsson A, Krumholz HM. Leveraging remote physiologic monitoring in the COVID-19 pandemic to improve care af- ter cardiovascular hospitalizations. Circ Cardiovasc Qual Outcomes. 2021;14:e007618. doi: 10.1161/CIRCOUTCOMES.120.007618 102.</note>
</biblStruct>

<biblStruct xml:id="b102">
	<monogr>
		<title level="m" type="main" xml:id="_Wb6skhB">AAMC regulatory resource: 2021 Medicare coverage of remote physiologic monitoring (RPM)</title>
		<author>
			<persName><forename type="first">G</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Stewart</surname></persName>
		</author>
		<ptr target="https://www.aamc.org/media/55306/download103" />
		<imprint>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lee G, Stewart K. AAMC regulatory resource: 2021 Medicare coverage of remote physiologic monitoring (RPM). 2021. https://www.aamc.org/ media/55306/download 103.</note>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main" xml:id="_adfq2JS">Cost-effectiveness of screening for atrial fibrillation using wearable devices</title>
		<author>
			<persName><forename type="first">W</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Khurshid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Singer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Atlas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Ashburner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Ellinor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Mcmanus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Lubitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chhatwal</surname></persName>
		</author>
		<idno type="DOI">10.1001/jamahealthforum.2022.2419104</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_S3DZ7MT">JAMA Health Forum</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">222419</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chen W, Khurshid S, Singer DE, Atlas SJ, Ashburner JM, Ellinor PT, McManus DD, Lubitz SA, Chhatwal J. Cost-effectiveness of screen- ing for atrial fibrillation using wearable devices. JAMA Health Forum. 2022;3:e222419. doi: 10.1001/jamahealthforum.2022.2419 104.</note>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main" xml:id="_G4PcB8y">The influence of wearables on health care outcomes in chronic disease: systematic review</title>
		<author>
			<persName><forename type="first">G</forename><surname>Mattison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Canfell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Forrester</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dobbins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Töyräs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sullivan</surname></persName>
		</author>
		<idno type="DOI">10.2196/36690105</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_CzRY7nU">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page">36690</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mattison G, Canfell O, Forrester D, Dobbins C, Smith D, Töyräs J, Sullivan C. The influence of wearables on health care outcomes in chronic disease: sys- tematic review. J Med Internet Res. 2022;24:e36690. doi: 10.2196/36690 105.</note>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main" xml:id="_ZatYU6n">Accuracy of fitbit devices: systematic review and narrative syntheses of quantitative data</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Feehan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Geldman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Sayre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Ezzat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Yoo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Hamilton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.2196/10527106</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QpWjuad">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">10527</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Feehan LM, Geldman J, Sayre EC, Park C, Ezzat AM, Yoo JY, Hamilton CB, Li LC. Accuracy of fitbit devices: systematic review and narrative syn- theses of quantitative data. JMIR Mhealth Uhealth. 2018;6:e10527. doi: 10.2196/10527 106.</note>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main" xml:id="_QJcNjSd">Concurrent validity of wearable activity trackers under free-living conditions</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Brooke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>An</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Noble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Berg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.1519/jsc.0000000000001571107</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SzmfF5W">J Strength Cond Res</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1097" to="1106" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Brooke SM, An HS, Kang SK, Noble JM, Berg KE, Lee JM. Concurrent validity of wearable activity trackers under free-living conditions. J Strength Cond Res. 2017;31:1097-1106. doi: 10.1519/jsc.0000000000001571 107.</note>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main" xml:id="_UetGd2h">Validity evaluation of the fitbit charge2 and the garmin vivosmart HR+ in freeliving environments in an older adult cohort</title>
		<author>
			<persName><forename type="first">S</forename><surname>Tedesco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ancillao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Timmons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Barton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Flynn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename></persName>
		</author>
		<idno type="DOI">10.2196/13084108</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7b4wzCa">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">13084</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tedesco S, Sica M, Ancillao A, Timmons S, Barton J, O&apos;Flynn B. Validity evaluation of the fitbit charge2 and the garmin vivosmart HR+ in free- living environments in an older adult cohort. JMIR Mhealth Uhealth. 2019;7:e13084. doi: 10.2196/13084 108.</note>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main" xml:id="_wFNXW4C">Usefulness of modern activity trackers for monitoring exercise behavior in chronic cardiac patients: validation study</title>
		<author>
			<persName><forename type="first">C</forename><surname>Herkert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Kraal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ema</forename><surname>Van Loon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Hooff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hmc</forename><surname>Kemps</surname></persName>
		</author>
		<idno type="DOI">10.2196/15045109</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zrPD6Hd">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">15045</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Herkert C, Kraal JJ, van Loon EMA, van Hooff M, Kemps HMC. Usefulness of modern activity trackers for monitoring exercise behavior in chronic car- diac patients: validation study. JMIR Mhealth Uhealth. 2019;7:e15045. doi: 10.2196/15045 109.</note>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main" xml:id="_jmjFcrd">Federated learning: challenges, methods, and future directions</title>
		<author>
			<persName><forename type="first">T</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Sahu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Talwalkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.1109/msp.2020.2975749110</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mKJFdH7">IEEE Signal Process Mag</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="50" to="60" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Li T, Sahu AK, Talwalkar A, Smith V. Federated learning: challenges, meth- ods, and future directions. IEEE Signal Process Mag. 2020;37:50-60. doi: 10.1109/msp.2020.2975749 110</note>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main" xml:id="_KkP4Gcy">Machine learning in arrhythmia and electrophysiology</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Trayanova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Popescu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Shade</surname></persName>
		</author>
		<idno type="DOI">10.1161/circresaha.120.317872111</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_t4eDTbF">Circ Res</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="page" from="544" to="566" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Trayanova NA, Popescu DM, Shade JK. Machine learning in ar- rhythmia and electrophysiology. Circ Res. 2021;128:544-566. doi: 10.1161/circresaha.120.317872 111</note>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main" xml:id="_38Vbnzd">State-of-the-art deep learning in cardiovascular image analysis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Litjens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ciompi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Wolterink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>De Vos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Leiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Teuwen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Išgum</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jcmg.2019.06.009112</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tgzmEK5">JACC Cardiovasc Imaging</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1549" to="1565" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Litjens G, Ciompi F, Wolterink JM, de Vos BD, Leiner T, Teuwen J, Išgum I. State-of-the-art deep learning in cardiovascular image analysis. JACC Cardiovasc Imaging. 2019;12:1549-1565. doi: 10.1016/j.jcmg.2019.06.009 112</note>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main" xml:id="_fhcG7Me">Ethical and legal challenges of artificial intelligence-driven healthcare</title>
		<author>
			<persName><forename type="first">S</forename><surname>Gerke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Minssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cohen</surname></persName>
		</author>
		<idno type="DOI">10.1016/b978-0-12-818438-7.00012-5</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_SJmMCn9">Artificial Intelligence in Healthcare</title>
		<imprint>
			<biblScope unit="page">113</biblScope>
			<date type="published" when="2020">2020</date>
			<publisher>Elsevier</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Gerke S, Minssen T, Cohen G. Ethical and legal challenges of artificial intelligence-driven healthcare. Artificial Intelligence in Healthcare. Elsevier; 2020;295-336. 113</note>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main" xml:id="_hgC62JC">Explainability for artificial intelligence in healthcare: a multidisciplinary perspective</title>
		<author>
			<persName><forename type="first">J</forename><surname>Amann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Blasimme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vayena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Frey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">I</forename><surname>Madai</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12911-020-01332-6</idno>
		<ptr target="http://ahajournals.org" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_wgXa9Pe">BMC Med Inform Decis Mak</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page">310</biblScope>
			<date type="published" when="2020-06-08">2020. June 8, 2025</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Amann J, Blasimme A, Vayena E, Frey D, Madai VI. Explainability for arti- ficial intelligence in healthcare: a multidisciplinary perspective. BMC Med Inform Decis Mak. 2020;20:310. doi: 10.1186/s12911-020-01332-6 Downloaded from http://ahajournals.org by on June 8, 2025</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
